|
 | aCGH: 226
|
Parkin B, Erba H, Ouillette P, Roulston D, Purkayastha A, Karp J, Talpaz M, et al.
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
Blood, 2010, .
(PMID 20729466)
|
|
| aCGH: 20
|
Micci F, Skotheim RI, Haugom L, Weimer J, Eibak AM, Abeler VM, Trope CG, Arnold N, et al.
Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes.
Genes, chromosomes & cancer, 2010, .
(PMID 20725991)
|
|
 | aCGH: 55
|
Shao L, Kang SH, Li J, Hixson P, Taylor J, Yatsenko SA, Shaw CA, Milosavljevic A, et al.
Array Comparative Genomic Hybridization Detects Chromosomal Abnormalities in Hematological Cancers That Are Not Detected by Conventional Cytogenetics.
The Journal of molecular diagnostics : JMD, 2010, .
(PMID 20724749)
|
|
| aCGH: 20
|
Hsiao YH, Su YA, Tsai HD, Mason JT, Chou MC, and Man YG.
Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.
Int J Biol Sci, 6(5) 2010, 428-42.
(PMID 20714441)
|
|
| aCGH: 178
|
Abkevich V, Iliev D, Timms KM, Tran T, Skolnick M, Lanchbury JS, et al.
Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization.
J Biomed Biotechnol, 2010 2010.
(PMID 20706610)
|
|
| aCGH: 354
|
Addou-Klouche L, Adelaide J, Finetti P, Cervera N, Ferrari A, Bekhouche I, et al.
Loss, mutation and deregulation of L3MBTL4 in breast cancers.
Mol Cancer, 9(1) 2010, 213.
(PMID 20698951)
|
|
| aCGH: 38
|
Luan SL, Boulanger E, Ye H, Chanudet E, Johnson N, Hamoudi RA, Bacon CM, Liu H, et al.
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.
The Journal of pathology, 2010, .
(PMID 20690162)
|
|
| aCGH: 3
|
Cottrell CE, Prior TW, Pyatt R, Astbury C, Reshmi S, Bartholomew D, Atkin J, et al.
Unexpected detection of dystrophin gene deletions by array comparative genomic hybridization.
American journal of medical genetics Part A, 2010, .
(PMID 20683981)
|
|
| aCGH: 13
|
Kim J, Lee SG, Song J, Kim SJ, Rha SY, Lee KA, Park TS, and Choi JR.
Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia.
Cancer Genetics and Cytogenetics, 201(2) 2010, 73-80.
(PMID 20682390)
|
|
| aCGH: 181
|
Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, et al.
Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma.
PLoS Med, 7(7) 2010, e1000315.
(PMID 20668658)
|
|
| aCGH: 20
|
Gunn S, Yeh IT, Lytvak I, Tirtorahardjo B, Dzidic N, Zadeh S, Kim J, McCaskill C, et al.
Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.
BMC Cancer, 10(1) 2010, 396.
(PMID 20667129)
|
|
| aCGH: 10
|
Ali L, Helm T, Cheney R, Conroy J, Sait S, Guitart J, and Gerami P.
Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Int J Clin Exp Pathol, 3(6) 2010, 593-99.
(PMID 20661407)
|
|
| aCGH: 8
|
Tran-Thanh D, Arneson NC, Pintilie M, Deliallisi A, Warren KS, Bane A, et al.
Amplification of the prolactin receptor gene in mammary lobular neoplasia.
Breast Cancer Res Treat, 2010.
(PMID 20658264)
|
|
| aCGH: 41
|
Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, et al.
Copy number and gene expression differences between African American and Caucasian American prostate cancer.
J Transl Med, 8(1) 2010, 70.
(PMID 20649978)
|
|
| aCGH: 56
|
Lai LA, Kostadinov R, Barrett MT, Peiffer DA, Pokholok D, Odze RD, Sanchez CA, et al.
Deletion at Fragile Sites is a Common and Early Event in Barretts Esophagus.
Mol Cancer Res, 2010.
(PMID 20647332)
|
|
| aCGH: 22
|
Mackinnon RN, Selan C, Wall M, Baker E, Nandurkar H, and Campbell LJ.
The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion.
Genes Chromosomes Cancer, 2010.
(PMID 20645416)
|
|
| aCGH: 47
|
Gutierrez A, Dahlberg SE, Neuberg DS, Zhang J, Grebliunaite R, Sanda T, Protopopov A, et al.
Absence of Biallelic TCR{gamma} Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol, 2010.
(PMID 20644084)
|
|
| aCGH: 2
|
Yusenko MV, Nagy A, and Kovacs G.
Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of . . .
Cancer Genet Cytogenet, 201(1) 2010, 15-23.
(PMID 20633763)
|
|
| aCGH: 56
|
Tomioka N, Morita K, Kobayashi N, Tada M, Itoh T, Saitoh S, Kondo M, Takahashi N, et al.
Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers.
Cancer Genet Cytogenet, 201(1) 2010, 6-14.
(PMID 20633762)
|
|
| aCGH: 27
|
Isinger-Ekstrand A, Johansson J, Ohlsson M, Francis P, Staaf J, Jonsson M, Borg A, et al.
Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array--comparative genomic hybridization.
Cancer Genet Cytogenet, 200(2) 2010, 120-26.
(PMID 20620594)
|
|
| aCGH: 114
|
Walker BA, Leone PE, Chiecchio L, Dickens NJ, Jenner MW, Boyd KD, Johnson DC, et al.
A compendium of myeloma associated chromosomal copy number abnormalities and their prognostic value.
Blood, 2010.
(PMID 20616218)
|
|
| aCGH: 74
|
Ishida Y, Takabatake T, Kakinuma S, Doi K, Yamauchi K, Kaminishi M, Kito S, Ohta Y, et al.
Genomic and gene expression signatures of radiation in medulloblastomas after low-dose irradiation in Ptch1 heterozygous mice.
Carcinogenesis, 2010.
(PMID 20616149)
|
|
| aCGH: 183
|
Joosse SA, Brandwijk KI, Devilee P, Wesseling J, Hogervorst FB, Verhoef S, et al.
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Breast Cancer Res Treat, 2010.
(PMID 20614180)
|
|
| aCGH: 80
|
Morrison C, Miecznikowski J, Darcy KM, Dolce JM, Kandel E, Erwin DO, Liu S, et al.
A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome.
Genes Chromosomes Cancer, 49(9) 2010, 791-802.
(PMID 20607851)
|
|
| aCGH: 1
|
Kim JE, Woo KS, Kim KE, Kim SH, Park JI, Shaffer LG, and Han JY.
A Rare Case of Acute Lymphoblastic Leukemia with t(12;17)(p13;q21).
Korean J Lab Med, 30(3) 2010, 239-43.
(PMID 20603582)
|
|
| aCGH: 22
|
Kang JU, Koo SH, Kwon KC, and Park JW.
Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.
Int J Oncol, 37(2) 2010, 327-35.
(PMID 20596660)
|
|
| aCGH: 46
|
Brosens RP, Haan JC, Carvalho B, Rustenburg F, Grabsch H, Quirke P, Engel AF, et al.
Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
J Pathol, 221(4) 2010, 411-24.
(PMID 20593488)
|
|
| aCGH: 112
|
Cooke SL, Ng CK, Melnyk N, Garcia MJ, Hardcastle T, Temple J, Langdon S, Huntsman D, et al.
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.
Oncogene, 2010.
(PMID 20581869)
|
|
| aCGH: 359
|
Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, Hegardt C, et al.
Genomic subtypes of breast cancer identified by array comparative genomic hybridization display distinct molecular and clinical characteristics.
Breast Cancer Res, 12(3) 2010, R42.
(PMID 20576095)
|
|
 | aCGH: 63
|
Bax DA, Mackay A, Little SE, Carvalho D, Viana-Pereira M, Tamber N, Grigoriadis AE, et al.
A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.
Clin Cancer Res, 16(13) 2010, 3368-77.
(PMID 20570930)
|
|
| aCGH: 25
|
Hosein AN, Wu M, Arcand SL, Lavallee S, Hebert J, Tonin PN, and Basik M.
Breast Carcinoma-Associated Fibroblasts Rarely Contain p53 Mutations or Chromosomal Aberrations.
Cancer Res, 2010.
(PMID 20570891)
|
|
| aCGH: 302
|
Lu X, Zhang K, Van Sant C, Coon J, and Semizarov D.
An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.
BMC Med Genomics, 3(1) 2010, 23.
(PMID 20569491)
|
|
| aCGH: 97
|
Parris TZ, Danielsson A, Nemes S, Kovacs A, Delle U, Fallenius G, Mollerstrom E, et al.
Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma.
Clin Cancer Res, 2010.
(PMID 20551037)
|
|
| aCGH: 25
|
Astolfi A, Nannini M, Pantaleo MA, Di Battista M, Heinrich MC, Santini D, Catena F, et al.
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number.
Lab Invest, 2010.
(PMID 20548289)
|
|
| aCGH: 104
|
Gast A, Scherer D, Chen B, Bloethner S, Melchert S, Sucker A, Hemminki K, et al.
Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Genes Chromosomes Cancer, 49(8) 2010, 733-45.
(PMID 20544847)
|
|
| aCGH: 97
|
Fles R, Hoogendoorn WE, Platteel I, Scheerman CE, de Leeuw-Mantel G, Mourits MJ, et al.
Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
Genes Chromosomes Cancer, 49(8) 2010, 699-710.
(PMID 20544844)
|
|
| aCGH: 10
|
Lin TT, Letsolo BT, Jones RE, Rowson J, Pratt G, Hewamana S, Fegan C, Pepper C, et al.
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukaemia: evidence for a telomere crisis.
Blood, 2010.
(PMID 20538793)
|
|
| aCGH: 292
|
Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, et al.
Molecular staging of intracranial ependymoma in children and adults.
J Clin Oncol, 28(19) 2010, 3182-90.
(PMID 20516456)
|
|
| aCGH: 15
|
Han S, Park K, Shin E, Kim HJ, Kim JY, Kim JY, and Gwak G.
Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer.
Oncol Rep, 24(1) 2010, 121-28.
(PMID 20514452)
|
|
| aCGH: 40
|
Brosens RP, Belt EJ, Haan JC, Buffart TE, Carvalho B, Grabsch H, Quirke P, Cuesta MA, et al.
Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.
Cell Oncol, 2010.
(PMID 20505237)
|
|
| aCGH: 95
|
Parkin B, Ouillette P, Wang Y, Liu Y, Wright W, Roulston D, Purkayastha A, Dressel A, et al.
NF1 INACTIVATION IN ADULT ACUTE MYELOGENOUS LEUKEMIA.
Clin Cancer Res, 2010.
(PMID 20505189)
|
|
| aCGH: 100
|
Eide MB, Liestol K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, et al.
Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.
Blood, 2010.
(PMID 20505157)
|
|
| aCGH: 10
|
Duns G, van den Berg E, van Duivenbode I, Osinga J, Hollema H, Hofstra RM, et al.
Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.
Cancer Res, 70(11) 2010, 4287-91.
(PMID 20501857)
|
|
| aCGH: 32
|
Meyniel JP, Cottu PH, Decraene C, Stern MH, Couturier J, Lebigot I, Nicolas A, et al.
A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast . . .
BMC Cancer, 10 2010, 222.
(PMID 20492709)
|
|
| CGH: 11
aCGH: 34
|
Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, Sturm D, Wittmann A, et al.
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
J Clin Oncol, 28(18) 2010, 3054-60.
(PMID 20479417)
|
|
| aCGH: 88
|
Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, et al.
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.
Journal of Clinical Oncology, 28(18) 2010, 3061-68.
(PMID 20479398)
|
|
| aCGH: 131
|
Toedt G, Barbus S, Wolter M, Felsberg J, Tews B, Blond F, Sabel MC, Hofmann S, et al.
Molecular signatures classify astrocytic gliomas by IDH1 mutation status.
Int J Cancer, 2010.
(PMID 20473936)
|
|
| aCGH: 3
|
Larsson N, Billstrom R, Lilljebjorn H, Lassen C, Richter J, Ekblom M, et al.
Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
Cancer Genet Cytogenet, 199(2) 2010, 89-95.
(PMID 20471511)
|
|
| aCGH: 148
|
Lin DC, Shi ZZ, Xue LY, Chen W, Xu X, Han YL, Lv N, and Wang MR.
[Expression of cell cycle related proteins cyclin D1, p53 and p21WAF1/Cip1 in esophageal squamous cell carcinoma.].
Yi Chuan, 32(5) 2010, 455-60.
(PMID 20466633)
|
|
| aCGH: 207
|
Williams SV, Platt FM, Hurst CD, Aveyard JS, Taylor CF, Pole JC, Garcia MJ, et al.
High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.
Genes Chromosomes Cancer, 49(7) 2010, 642-59.
(PMID 20461757)
|
|
| aCGH: 52
|
Kumps C, Van Roy N, Heyrman L, Goossens D, Del-Favero J, Noguera R, Vandesompele J, et al.
Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma.
BMC Genomics, 11 2010, 298.
(PMID 20459859)
|
|
| aCGH: 40
|
Berg M, Agesen TH, Thiis-Evensen E, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, et al.
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.
Mol Cancer, 9 2010, 100.
(PMID 20459617)
|
|
| aCGH: 200
|
Staaf J, Jonsson G, Ringner M, Vallon-Christersson J, Grabau D, Arason A, et al.
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Breast Cancer Res, 12(3) 2010, R25.
(PMID 20459607)
|
|
| aCGH: 2
|
Geyer FC, Lambros MB, Natrajan R, Mehta R, Mackay A, Savage K, Parry S, Ashworth A, et al.
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.
Mod Pathol, 23(7) 2010, 951-60.
(PMID 20453835)
|
|
| aCGH: 2
|
Wolf M, Korja M, Karhu R, Edgren H, Kilpinen S, Ojala K, Mousses S, Kallioniemi A, et al.
Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.
BMC Cancer, 10 2010, 181.
(PMID 20444257)
|
|
| aCGH: 15
|
van Roon EH, van Puijenbroek M, Middeldorp A, van Eijk R, de Meijer EJ, Erasmus D, et al.
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
BMC Cancer, 10 2010, 180.
(PMID 20444249)
|
|
| aCGH: 75
|
Okamoto R, Ogawa S, Nowak D, Kawamata N, Akagi T, Kato M, Sanada M, Weiss T, et al.
Genomic profiling of adult acute lymphoblastic leukemia (ALL) by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric ALL.
Haematologica, 2010, .
(PMID 20435627)
|
|
| aCGH: 5
|
Hovatta O, Jaconi M, Töhönen V, Béna F, Gimelli S, Bosman A, Holm F, Wyder S, et al.
A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.
PLoS ONE, 5(4) 2010, e10263.
(PMID 20428235)
|
|
| aCGH: 68
|
Ernst T, Chase A, Zoi K, Waghorn K, Hidalgo-Curtis C, Score J, Jones A, Grand F, et al.
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.
Haematologica, 2010, .
(PMID 20421268)
|
|
| aCGH: 10
|
Nowak NJ, Sait SN, Zeidan A, Deeb G, Gaile D, Liu S, Ford L, Wallace PK, Wang ES, et al.
Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia.
Cancer Genet. Cytogenet, 199(1) 2010, 15-20.
(PMID 20417863)
|
|
| aCGH: 41
|
Boultwood J, Perry J, Zaman R, Fernandez-Santamaria C, Littlewood T, Kusec R, et al.
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK, 2010, .
(PMID 20410925)
|
|
| aCGH: 53
|
Sandgren J, Diaz de Stahl T, Andersson R, Menzel U, Piotrowski A, Nord H, et al.
Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array-CGH analysis.
Endocrine-related cancer, 2010, .
(PMID 20410162)
|
|
| aCGH: 30
|
Bae JS, Choi JS, Baik SH, Park WC, Song BJ, Kim JS, Lim Y, and Jung SS.
Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast.
World journal of surgical oncology, 8(1) 2010, 32.
(PMID 20409316)
|
|
| aCGH: 103
|
Lindgren D, Frigyesi A, Gudjonsson S, Sjödahl G, Hallden C, Chebil G, Veerla S, et al.
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
Cancer Res, 70(9) 2010, 3463-72.
(PMID 20406976)
|
|
| aCGH: 160
|
Buckley PG, Alcock L, Bryan K, Bray I, Schulte JH, Schramm A, Eggert A, Mestdagh P, et al.
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.
Clin Cancer Res, 16(11) 2010, 2971-78.
(PMID 20406844)
|
|
| aCGH: 41
|
Nobusawa S, Lachuer J, Wierinckx A, Kim YH, Huang J, Legras C, Kleihues P, et al.
Intratumoral Patterns of Genomic Imbalance in Glioblastomas.
Brain pathology (Zurich, Switzerland), 2010, .
(PMID 20406234)
|
|
| aCGH: 10
|
Alizadeh AA, Bohen SP, Lossos C, Martinez-Climent JA, Ramos JC, Cubedo-Gil E, et al.
Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.
Leukemia & lymphoma, 2010, .
(PMID 20370541)
|
|
| aCGH: 1
|
Lasa A, Ramón Y Cajal T, Llort G, Suela J, Cigudosa JC, Cornet M, Alonso C, et al.
Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation.
Breast cancer research and treatment, 2010, .
(PMID 20369283)
|
|
| aCGH: 41
|
Möllerström E, Delle U, Danielsson A, Parris T, Olsson B, Karlsson P, et al.
High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
Cancer Genet. Cytogenet, 198(2) 2010, 79-89.
(PMID 20362222)
|
|
| aCGH: 29
|
Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, et al.
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.
Nat Biotechnol, 28(4) 2010, 371-77.
(PMID 20351689)
|
|
| aCGH: 53
|
Steidl C, Telenius A, Shah SP, Farinha P, Barclay L, Boyle M, Connors JM, Horsman DE, et al.
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.
Blood, 2010, .
(PMID 20339089)
|
|
| aCGH: 34
|
Tada M, Kanai F, Tanaka Y, Sanada M, Nannya Y, Tateishi K, Ohta M, Asaoka Y, Seto M, et al.
Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer.
Cancer science, 2010, .
(PMID 20331625)
|
|
| aCGH: 55
|
Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, et al.
TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
J Clin Oncol, 28(12) 2010, 1995-2001.
(PMID 20308654)
|
|
| aCGH: 11
|
Kim KY, Kim J, Kim HJ, Nam W, and Cha IH.
A method for detecting significant genomic regions associated with oral squamous cell carcinoma using aCGH.
Med Biol Eng Comput, 48(5) 2010, 459-68.
(PMID 20306232)
|
|
| aCGH: 60
|
Usvasalo A, Elonen E, Saarinen-Pihkala UM, Räty R, Harila-Saari A, Koistinen P, et al.
Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization . . .
Leukemia research, 2010, .
(PMID 20303590)
|
|
| aCGH: 21
|
Sung JS, Park KH, and Kim YH.
Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
Cancer Genet. Cytogenet, 198(1) 2010, 27-34.
(PMID 20303011)
|
|
| aCGH: 4
|
Nasri S, Anjomshoaa A, Song S, Guilford P, McNoe L, Black M, Phillips V, Reeve A, et al.
Oligonucleotide array outperforms SNP array on formalin-fixed paraffin-embedded clinical samples.
Cancer Genet. Cytogenet, 198(1) 2010, 1-6.
(PMID 20303007)
|
|
| aCGH: 2
|
Buganim Y, Goldstein I, Lipson D, Milyavsky M, Polak-Charcon S, Mardoukh C, et al.
A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.
PLoS ONE, 5(3) 2010, e9657.
(PMID 20300178)
|
|
| aCGH: 219
|
Xia XQ, Jia Z, Porwollik S, Long F, Hoemme C, Ye K, Müller-Tidow C, McClelland M, et al.
Evaluating oligonucleotide properties for DNA microarray probe design.
Nucleic acids research, 2010, .
(PMID 20236987)
|
|
| aCGH: 246
|
Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, et al.
PHF6 mutations in T-cell acute lymphoblastic leukemia.
Nat Genet, 42(4) 2010, 338-42.
(PMID 20228800)
|
|
| aCGH: 3
|
Pedranzini L, Mottadelli F, Ronzoni S, Rossella F, Ferracin M, Magnani I, Roversi G, et al.
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34(+)38(-) compartment.
Leukemia research, 2010, .
(PMID 20227111)
|
|
| aCGH: 131
|
Chng WJ, Gertz MA, Chung TH, Van Wier S, Keats JJ, Baker A, Bergsagel PL, Carpten J, et al.
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in . . .
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK, 24(4) 2010, 833-42.
(PMID 20220778)
|
|
| aCGH: 5
|
Wang Y, Yang D, Cogdell D, Hu L, Xue F, Broaddus R, and Zhang W.
Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma.
Technol Cancer Res Treat, 9(2) 2010, 179-89.
(PMID 20218740)
|
|
| aCGH: 10
|
Yang J, Yang D, Cogdell D, Du X, Li H, Pang Y, Sun Y, Hu L, Sun B, Trent J, Chen K, et al.
APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.
Technol Cancer Res Treat, 9(2) 2010, 161-69.
(PMID 20218738)
|
|
| aCGH: 20
|
Deffenbacher KE, Iqbal J, Liu Z, Fu K, and Chan WC.
Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: an integrated analysis of DNA copy number and gene expression.
J Acquir Immune Defic Syndr, 54(1) 2010, 18-26.
(PMID 20216076)
|
|
| aCGH: 3
|
Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, et al.
Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron.
Cancer Res, 70(6) 2010, 2191-203.
(PMID 20215517)
|
|
| aCGH: 33
|
Flanagan JM, Cocciardi S, Waddell N, Johnstone CN, Marsh A, Henderson S, Simpson P, et al.
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Am J Hum Genet, 86(3) 2010, 420-33.
(PMID 20206335)
|
|
| aCGH: 50
|
Obrador-Hevia A, Chin SF, Gonzalez S, Rees J, Vilardell F, Greenson JK, Cordero D, et al.
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
J Pathol, 2010.
(PMID 20196079)
|
|
| aCGH: 41
|
Yasar D, Karadogan I, Alanoglu G, Akkaya B, Luleci G, Salim O, Timuragaoglu A, et al.
Array comparative genomic hybridization analysis of adult acute leukemia patients.
Cancer Genet. Cytogenet, 197(2) 2010, 122-29.
(PMID 20193845)
|
|
| aCGH: 1
|
Soucek K, Gajdusková P, Brázdová M, Hýzdalová M, Kocí L, Vydra D, Trojanec R, et al.
Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation.
Cancer Genet. Cytogenet, 197(2) 2010, 107-16.
(PMID 20193843)
|
|
| aCGH: 1
|
Zuiverloon TC, Abas CS, van der Keur KA, Vermeij M, Tjin SS, van Tilborg AG, et al.
In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report.
BMC Urol, 10 2010, 5.
(PMID 20187926)
|
|
| aCGH: 30
|
Yang HH, Hu N, Wang C, Ding T, Dunn BK, Goldstein AM, Taylor PR, et al.
Influence of genetic background and tissue types on global DNA methylation patterns.
PLoS ONE, 5(2) 2010, e9355.
(PMID 20186319)
|
|
| aCGH: 1
|
Jung SH, Yim SH, Hu HJ, Jung CK, Lee SH, Kim DH, and Chung YJ.
Copy number alterations and expression profiles of candidate genes in a pulmonary inflammatory myofibroblastic tumor.
Lung Cancer, 2010.
(PMID 20185201)
|
|
| aCGH: 48
|
Diosdado B, Buffart TE, Watkins R, Carvalho B, Ylstra B, Tijssen M, Bolijn AS, et al.
High-Resolution Array Comparative Genomic Hybridization in Sporadic and Celiac Disease-Related Small Bowel Adenocarcinomas.
Clin Cancer Res, 16(5) 2010, 1391-401.
(PMID 20179237)
|
|
| aCGH: 826
|
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, et al.
The landscape of somatic copy-number alteration across human cancers.
Nature, 463(7283) 2010, 899-905.
(PMID 20164920)
|
|
| aCGH: 153
|
Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, et al.
Wide diversity of PAX5 alterations in B-ALL: a GFCH (Groupe Francophone de Cytogenetique Hematologique) study.
Blood, 2010.
(PMID 20160164)
|
|
| CGH: 58
aCGH: 20
|
Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, et al.
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group.
J Clin Oncol, 2010.
(PMID 20159821)
|
|
| aCGH: 15
|
Boldt V, Stacher E, Halbwedl I, Popper H, Hultschig C, Moinfar F, Ullmann R, et al.
Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression.
Genes Chromosomes Cancer, 49(5) 2010, 463-70.
(PMID 20155841)
|
|
| aCGH: 1
|
Ling ZQ, Mukaisho KI, Yamamoto H, Chen KH, Asano S, Araki Y, Sugihara H, Mao WM, et al.
Initiation of malignancy by duodenal contents reflux and the role of ezrin in developing esophageal squamous cell carcinoma.
Cancer Sci, 2009.
(PMID 20128822)
|
|
| aCGH: 132
|
Iwatsuki M, Mimori K, Sato T, Toh H, Yokobori T, Tanaka F, Ishikawa K, Baba H, et al.
Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance.
Int J Oncol, 36(3) 2010, 569-75.
(PMID 20126976)
|
|
| aCGH: 47
|
Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S, Neuberg D, et al.
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.
Blood, 2010.
(PMID 20124220)
|
|
| aCGH: 3
|
Min HS, Kang HG, Lee JH, Lee GK, and Ro JY.
Desmoplastic fibroma with malignant transformation.
Ann Diagn Pathol, 14(1) 2010, 50-55.
(PMID 20123458)
|
|
| CGH: 1
aCGH: 1
|
Golas MM, Gunawan B, Raab BW, Fuzesi L, and Lange B.
Malignant transformation of an untreated congenital sacrococcygeal teratoma: a amplification at 8q and 12p detected by comparative genomic hybridization.
Cancer Genet Cytogenet, 197(1) 2010, 95-98.
(PMID 20113846)
|
|
| aCGH: 598
|
Mattison J, Kool J, Uren AG, de Ridder J, Wessels L, Jonkers J, Bignell GR, Butler A, et al.
Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach.
Cancer Res, 70(3) 2010, 883-95.
(PMID 20103622)
|
|
| aCGH: 47
|
Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, et al.
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.
J Pathol, 220(5) 2009, 562-73.
(PMID 20099298)
|
|
| aCGH: 1
|
Tang J, Le S, Sun L, Yan X, Zhang M, Macleod J, Leroy B, Northrup N, Ellis A, et al.
Copy number abnormalities in sporadic canine colorectal cancers.
Genome Res, 20(3) 2010, 341-50.
(PMID 20086242)
|
|
| aCGH: 1
|
Lee J, Wang J, Torbenson M, Lu Y, Liu QZ, and Li S.
Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization.
Cancer Genet Cytogenet, 196(2) 2010, 179-83.
(PMID 20082856)
|
|
| aCGH: 92
|
Nacheva EP, Brazma D, Virgili A, Howard-Reeves J, Chanalaris A, Gancheva K, et al.
Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.
BMC Genomics, 11 2010, 41.
(PMID 20082691)
|
|
| aCGH: 16
|
Gaiser T, Kutzner H, Palmedo G, Siegelin MD, Wiesner T, Bruckner T, Hartschuh W, et al.
Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.
Mod Pathol, 23(3) 2010, 413-19.
(PMID 20081813)
|
|
| CGH: 4
aCGH: 12
|
Jarosova M, Urbankova H, Plachy R, Papajik T, Holzerova M, Balcarkova J, Pikalova Z, et al.
Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangement.
Leuk Lymphoma, 51(2) 2010, 304-13.
(PMID 20078324)
|
|
| aCGH: 25
|
Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, Hamoudi R, Liu H, Dong G, et al.
Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
J Pathol, 2009.
(PMID 20077527)
|
|
| aCGH: 31
|
Leprêtre F, Villenet C, Quief S, Nibourel O, Jacquemin C, Troussard X, Jardin F, et al.
Waved aCGH: to smooth or not to smooth.
Nucleic acids research, 38(7) 2010, e94.
(PMID 20071741)
|
|
| aCGH: 59
|
Tsuji K, Kawauchi S, Saito S, Furuya T, Ikemoto K, Nakao M, Yamamoto S, Oka M, et al.
Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: Comparison of the CGH profiles between cancer cell lines . . .
BMC Cancer, 10(1) 2010, 15.
(PMID 20070913)
|
|
| aCGH: 159
|
Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T, Weiss T, Nowak D, et al.
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.
Blood, 2010.
(PMID 20068225)
|
|
| aCGH: 68
|
Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers E, Joosse SA, et al.
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Clin Cancer Res, 16(2) 2010, 651-63.
(PMID 20068109)
|
|
| CGH: 72
aCGH: 12
|
Matteucci C, Barba G, Varasano E, Vitale A, Mancini M, Testoni N, Cuneo A, et al.
Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study.
Br J Haematol, 2010.
(PMID 20067559)
|
|
| aCGH: 42
|
Murayama-Hosokawa S, Oda K, Nakagawa S, Ishikawa S, Yamamoto S, Shoji K, Ikeda Y, et al.
Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances . . .
Oncogene, 2010.
(PMID 20062086)
|
|
| aCGH: 21
|
Shiang CY, Qi Y, Wang B, Lazar V, Wang J, Fraser Symmans W, Hortobagyi GN, Andre F, et al.
Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Breast Cancer Res Treat, 2009.
(PMID 20024612)
|
|
| aCGH: 80
|
Galvan A, Falvella FS, Frullanti E, Spinola M, Incarbone M, Nosotti M, et al.
Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer.
Carcinogenesis, 2009.
(PMID 20022890)
|
|
| aCGH: 157
|
Bullinger L, Kronke J, Schon C, Radtke I, Urlbauer K, Botzenhardt U, Gaidzik V, et al.
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism . . .
Leukemia, 24(2) 2010, 438-49.
(PMID 20016533)
|
|
| aCGH: 151
|
Stegelmann F, Bullinger L, Griesshammer M, Holzmann K, Habdank M, Kuhn S, Maile C, et al.
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations.
Haematologica, 2009.
(PMID 20015882)
|
|
| aCGH: 247
|
Usvasalo A, Ninomiya S, Raty R, Hollmen J, Saarinen-Pihkala UM, Elonen E, et al.
Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses.
Genes Chromosomes Cancer, 2009.
(PMID 20013897)
|
|
| aCGH: 22
|
Manner J, Radlwimmer B, Hohenberger P, Mossinger K, Kuffer S, Sauer C, Belharazem D, et al.
MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.
Am J Pathol, 176(1) 2010, 34-39.
(PMID 20008140)
|
|
| aCGH: 33
|
Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, Garaventa A, et al.
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma.
BMC Cancer, 9 2009, 441.
(PMID 20003513)
|
|
| aCGH: 24
|
Armengol G, Canellas A, Alvarez Y, Bastida P, Toledo JS, Perez-Iribarne MD, Camos M, et al.
Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia.
Leuk Lymphoma, 2009.
(PMID 20001230)
|
|
| aCGH: 277
|
Melchor L, Saucedo-Cuevas LP, Munoz-Repeto I, Rodriguez-Pinilla SM, Honrado E, et al.
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.
Breast Cancer Res, 11(6) 2009, R86.
(PMID 19995430)
|
|
| aCGH: 6
|
Curtis C, Lynch AG, Dunning MJ, Spiteri I, Marioni JC, Hadfield J, Chin SF, et al.
The pitfalls of platform comparison: DNA copy number array technologies assessed.
BMC Genomics, 10 2009, 588.
(PMID 19995423)
|
|
| aCGH: 128
|
Kim YH, Kwei KA, Girard L, Salari K, Kao J, Pacyna-Gengelbach M, Wang P, et al.
Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
Oncogene, 2009.
(PMID 19966867)
|
|
| aCGH: 45
|
Nowak D, Ogawa S, Muschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, et al.
SNP array analysis of tyrosine kinase inhibitor (TKI) resistant chronic myeloid leukemia (CML) identifies heterogeneous secondary genomic alterations.
Blood, 2009.
(PMID 19965645)
|
|
| aCGH: 5
|
Prochazka P, Hrabeta J, Vicha A, and Eckschlager T.
Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and . . .
Cancer Genet Cytogenet, 196(1) 2010, 96-104.
(PMID 19963143)
|
|
| aCGH: 40
|
Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Collins VP, Van Meter T, Picard D, et al.
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.
Cancer Cell, 16(6) 2009, 533-46.
(PMID 19962671)
|
|
| aCGH: 81
|
Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, et al.
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.
Cancer Cell, 16(6) 2009, 463-74.
(PMID 19962665)
|
|
| aCGH: 20
|
Monzon FA, Alvarez K, Gatalica Z, Bridge JA, Nelson M, Kim HJ, et al.
Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism . . .
Arch Pathol Lab Med, 133(12) 2009, 1917-22.
(PMID 19961245)
|
|
| aCGH: 34
|
Waddell N, Arnold J, Cocciardi S, da Silva L, Marsh A, Riley J, Johnstone CN, et al.
Subtypes of familial breast tumours revealed by expression and copy number profiling.
Breast Cancer Res Treat, 2009.
(PMID 19960244)
|
|
| aCGH: 69
|
Molica S, Digiesi G, Vacca A, Mirabelli R, Todoerti K, Battaglia C, Morabito F, et al.
Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?
Adv Hematol, 2009 2009, 287974.
(PMID 19960063)
|
|
| aCGH: 110
|
Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, Wong M, Shen WT, Kebebew E, et al.
Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families.
Surgery, 146(6) 2009, 1073-80.
(PMID 19958934)
|
|
| aCGH: 98
|
Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, et al.
Somatic mutations of the Parkinsons disease-associated gene PARK2 in glioblastoma and other human malignancies.
Nat Genet, 42(1) 2010, 77-82.
(PMID 19946270)
|
|
| aCGH: 19
|
Tanaka S and Arii S.
Medical treatments: in association or alone, their role and their future perspectives : Novel molecular-targeted therapy for hepatocellular carcinoma.
J Hepatobiliary Pancreat Surg, 2009.
(PMID 19941009)
|
|
| aCGH: 9
|
Knutsen T, Padilla-Nash HM, Wangsa D, Barenboim-Stapleton L, Camps J, McNeil N, et al.
Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines.
Genes Chromosomes Cancer, 2009.
(PMID 19927377)
|
|
| aCGH: 1
|
Fraser CR, Wang W, Gomez M, Zhang T, Mathew S, Furman RR, Knowles DM, Orazi A, et al.
Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma . . .
Am J Clin Pathol, 132(6) 2009, 928-39.
(PMID 19926586)
|
|
| aCGH: 145
|
Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM, Alcock L, Mestdagh P, et al.
Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.
PLoS One, 4(11) 2009, e7850.
(PMID 19924232)
|
|
| aCGH: 14
|
Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, and Cerroni L.
Alterations of the Cell-Cycle Inhibitors p27(KIP1) and p16(INK4a) Are Frequent in Blastic Plasmacytoid Dendritic Cell Neoplasms.
J Invest Dermatol, 2009.
(PMID 19924135)
|
|
| aCGH: 47
|
Gabeau-Lacet D, Engler D, Gupta S, Scangas GA, Betensky RA, Barker FGn, Loeffler JS, et al.
Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.
J Neuropathol Exp Neurol, 68(10) 2009, 1155-65.
(PMID 19918127)
|
|
| aCGH: 109
|
Poulogiannis G, Ichimura K, Hamoudi RA, Luo F, Leung SY, Yuen ST, Harrison DJ, et al.
Prognostic relevance of DNA copy number changes in colorectal cancer.
J Pathol, 2009.
(PMID 19911421)
|
|
| aCGH: 50
|
Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, et al.
Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell . . .
J Hematol Oncol, 2 2009, 47.
(PMID 19909553)
|
|
| aCGH: 20
|
Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J, Riggs M, Eberling Y, et al.
Inferring tumor progression from genomic heterogeneity.
Genome Res, 20(1) 2010, 68-80.
(PMID 19903760)
|
|
| aCGH: 20
|
Beck AH, Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, Zhu S, Li R, et al.
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
Oncogene, 29(6) 2010, 845-54.
(PMID 19901961)
|
|
| aCGH: 55
|
Yang J, Cogdell D, Yang D, Hu L, Li H, Zheng H, Du X, Pang Y, Trent J, Chen K, et al.
Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.
Cancer Lett, 2009.
(PMID 19896763)
|
|
| aCGH: 310
|
Del Valle J, Feliubadalo L, Nadal M, Teule A, Miro R, Cuesta R, Tornero E, et al.
Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes.
Breast Cancer Res Treat, 2009.
(PMID 19894111)
|
|
| aCGH: 216
|
Hostetter G, Kim SY, Savage S, Gooden GC, Barrett M, Zhang J, Alla L, Watanabe A, et al.
Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples.
Nucleic Acids Res, 2009.
(PMID 19875416)
|
|
| aCGH: 45
|
Rousseau A, Idbaih A, Ducray F, Criniere E, Fevre-Montange M, Jouvet A, et al.
Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
J Neurooncol, 2009.
(PMID 19865800)
|
|
| aCGH: 4
|
Costa JL, Eijk PP, van de Wiel MA, ten Berge D, Schmitt F, Narvaez CJ, Welsh J, et al.
Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
BMC Genomics, 10 2009, 499.
(PMID 19863778)
|
|
| aCGH: 20
|
Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, Engel F, Hartmann C, Felsberg J, et al.
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
Clin Cancer Res, 15(21) 2009, 6541-50.
(PMID 19861460)
|
|
| aCGH: 2
|
Chen HK, Huang HY, Li CF, Ko SF, Changchien CC, Chen WJ, and Huang CC.
Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature.
Int J Gynecol Pathol, 28(6) 2009, 535-40.
(PMID 19851200)
|
|
| aCGH: 28
|
Caprini E, Cristofoletti C, Arcelli D, Fadda P, Citterich MH, Sampogna F, Magrelli A, et al.
Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays.
Cancer Res, 69(21) 2009, 8438-46.
(PMID 19843862)
|
|
| aCGH: 10
|
Rennstam K, Ringberg A, Cunliffe HE, Olsson H, Landberg G, and Hedenfalk I.
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
Genes Chromosomes Cancer, 49(1) 2010, 78-90.
(PMID 19839046)
|
|
| aCGH: 3
|
Yoshimoto M, Graham C, Chilton-MacNeill S, Lee E, Shago M, Squire J, Zielenska M, et al.
Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event.
Cancer Genet Cytogenet, 195(1) 2009, 1-11.
(PMID 19837261)
|
|
| aCGH: 14
|
Wu JC, Sun BS, Ren N, Ye QH, and Qin LX.
Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.
J Cancer Res Clin Oncol, 2009.
(PMID 19834740)
|
|
| aCGH: 53
|
Dachrut S, Banthaisong S, Sripa M, Paeyao A, Ho C, Lee SA, Kosinski C, Patil MA, et al.
DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.
Asian Pac J Cancer Prev, 10(4) 2009, 575-82.
(PMID 19827872)
|
|
| aCGH: 13
|
Cowell JK, Lo KC, Luce J, and Hawthorn L.
Interpreting aCGH-defined karyotypic changes in gliomas using copy number status, loss of heterozygosity and allelic ratios.
Exp Mol Pathol, 2009.
(PMID 19818351)
|
|
| aCGH: 84
|
Gong Y, Yao E, Shen R, Goel A, Arcila M, Teruya-Feldstein J, Zakowski MF, Frankel S, et al.
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507).
PLoS One, 4(10) 2009, e7273.
(PMID 19806209)
|
|
| aCGH: 13
|
Leunen K, Gevaert O, Daemen A, Vanspauwen V, Michils G, De Moor B, Moerman P, et al.
Recurrent copy number alterations in BRCA1-mutated ovarian tumors alter biological pathways.
Hum Mutat, 30(12) 2009, 1693-702.
(PMID 19802895)
|
|
| aCGH: 13
|
Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, et al.
T (brachyury) gene duplication confers major susceptibility to familial chordoma.
Nat Genet, 41(11) 2009, 1176-78.
(PMID 19801981)
|
|
| aCGH: 87
|
Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, et al.
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
Nat Genet, 41(11) 2009, 1238-42.
(PMID 19801978)
|
|
| aCGH: 37
|
Chase A, Ernst T, Fiebig A, Collins A, Grand F, Erben P, Reiter A, Schreiber S, et al.
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals.
Haematologica, 2009.
(PMID 19797732)
|
|
| aCGH: 91
|
Jung AC, Briolat J, Millon R, de Reynies A, Rickman D, Thomas E, Abecassis J, et al.
Biological and clinical relevance of transcriptionnally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.
Int J Cancer, 2009.
(PMID 19795456)
|
|
| aCGH: 4
|
Stejskalova E, Malis J, Snajdauf J, Pycha K, Urbankova H, Bajciova V, Stary J, et al.
Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas.
Cancer Genet Cytogenet, 194(2) 2009, 82-87.
(PMID 19781440)
|
|
| aCGH: 1
|
Woo KS, Kim KE, Kim KH, Kim SH, Park JI, Shaffer LG, and Han JY.
Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
Cancer Genet Cytogenet, 194(2) 2009, 71-74.
(PMID 19781438)
|
|
| aCGH: 73
|
Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, True LD, Roudier MP, et al.
Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer.
Cancer Res, 2009.
(PMID 19773449)
|
|
| aCGH: 1
|
Steensma DP, Neiger JD, Porcher JC, Keats JJ, Bergsagel PL, Dennis TR, Knudson RA, et al.
Rearrangements and Amplification of IER3 (IEX-1) Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes.
Cancer Res, 2009.
(PMID 19773435)
|
|
| aCGH: 33
|
Wang C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NC, Pintilie M, et al.
Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: An aCGH study.
Genes Chromosomes Cancer, 2009.
(PMID 19760610)
|
|
| aCGH: 41
|
Salgado R, Servitje O, Gallardo F, Vermeer MH, Ortiz-Romero PL, Karpova MB, Zipser MC, et al.
Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides.
J Invest Dermatol, 2009.
(PMID 19759554)
|
|
| aCGH: 1
|
Ciappetta P, DUrso PI, Cimmino A, Ingravallo G, Rossi R, Colamaria A, et al.
Intramedullary solitary fibrous tumor of dorsal spinal cord.
Neuropathology, 2009.
(PMID 19751244)
|
|
| aCGH: 203
|
Gunnarsson R, Isaksson A, Mansouri M, Goransson H, Jansson M, Cahill N, Rasmussen M, et al.
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed . . .
Leukemia, 24(1) 2010, 211-15.
(PMID 19741724)
|
|
| aCGH: 130
|
Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, et al.
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance.
Int J Cancer, 2009.
(PMID 19739118)
|
|
| aCGH: 2
|
Kitada K, Yamasaki T, and Aikawa S.
Amplification of the ABCB1 region accompanied by a short sequence of 200bp from chromosome 2 in lung cancer cells.
Cancer Genet Cytogenet, 194(1) 2009, 4-11.
(PMID 19737648)
|
|
| aCGH: 69
|
Kubo T, Kuroda Y, Shimizu H, Kokubu A, Okada N, Hosoda F, Arai Y, Nakamura Y, et al.
Resequencing and Copy Number Analysis of the Human Tyrosine Kinase Gene Family in Poorly Differentiated Gastric Cancer.
Carcinogenesis, 2009.
(PMID 19734198)
|
|
| aCGH: 23
|
Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N, Henke N, Li Z, et al.
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.
Cancer Cell, 16(3) 2009, 232-45.
(PMID 19732723)
|
|
| aCGH: 10
|
Stein L, Rothschild J, Luce J, Cowell JK, Thomas G, Bogdanova TI, Tronko MD, et al.
Copy Number and Gene Expression Alterations in Radiation-Induced Papillary Thyroid Carcinoma from Chernobyl Pediatric Patients.
Thyroid, 2009.
(PMID 19725780)
|
|
| aCGH: 18
|
Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, et al.
Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.
J Pathol, 2009.
(PMID 19718711)
|
|
| aCGH: 161
|
Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, et al.
Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.
Cancer Res, 69(18) 2009, 7357-65.
(PMID 19706770)
|
|
| aCGH: 24
|
Kim KY, Lee GY, Kim J, Jeung HC, Chung HC, and Rha SY.
Identification of significant regional genetic variations using continuous CNV values in aCGH data.
Genomics, 2009.
(PMID 19699295)
|
|
| aCGH: 63
|
Buffart TE, van Grieken NC, Tijssen M, Coffa J, Ylstra B, Grabsch HI, van de Velde CJ, et al.
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers.
Virchows Arch, 455(3) 2009, 213-23.
(PMID 19697059)
|
|
| aCGH: 39
|
Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, et al.
Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.
Histopathology, 55(2) 2009, 197-205.
(PMID 19694827)
|
|
| aCGH: 46
|
Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, et al.
Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer.
Genes Chromosomes Cancer, 48(11) 2009, 1002-17.
(PMID 19691111)
|
|
| aCGH: 28
|
Dimova I, Orsetti B, Negre V, Rouge C, Ursule L, Lasorsa L, Dimitrov R, Doganov N, et al.
Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis.
Tumori, 95(3) 2009, 357-66.
(PMID 19688977)
|
|
| aCGH: 13
|
Nordgren A, Corcoran M, Saaf A, Bremer A, Kluin-Nelemans HC, Schoumans J, et al.
Characterisation of Hairy Cell Leukaemia by tiling resolution Array-based Comparative Genome Hybridisation: a series of 13 cases and review of the literature.
Eur J Haematol, 2009.
(PMID 19682064)
|
|
| aCGH: 81
|
Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, Mansukhani M, et al.
Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.
Genes Chromosomes Cancer, 2009.
(PMID 19681120)
|
|
| aCGH: 36
|
Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, Signoroni S, et al.
Integrative approach for prioritizing cancer genes in sporadic colon cancer.
Genes Chromosomes Cancer, 48(11) 2009, 953-62.
(PMID 19672874)
|
|
| aCGH: 8
|
Pantaleo MA, Astolfi A, Di Battista M, Heinrich MC, Paterini P, Scotlandi K, et al.
Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target.
Int J Cancer, 2009.
(PMID 19672856)
|
|
| aCGH: 11
|
Buckley PG, Walsh SH, Laurell A, Sundstrom C, Roos G, Langford CF, Dumanski JP, et al.
Genome-wide microarray-based comparative genomic hybridization analysis of lymphoplasmacytic lymphomas reveals heterogeneous aberrations.
Leuk Lymphoma, 2009, 1-7.
(PMID 19672776)
|
|
| aCGH: 40
|
Girard N, Ostrovnaya I, Lau C, Park B, Ladanyi M, Finley D, Deshpande C, Rusch V, et al.
Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
Clin Cancer Res, 15(16) 2009, 5184-90.
(PMID 19671847)
|
|
| aCGH: 82
|
Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, Savic R, et al.
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
J Hepatol, 2009.
(PMID 19665249)
|
|
| aCGH: 11
|
Emerenciano M, Bungaro S, Cazzaniga G, Dorea MD, Coser VM, Magalhaes IQ, Biondi A, et al.
ETV6-RUNX1 fusion gene and additional genetic changes in infant leukemia: a genome-wide analysis.
Cancer Genet Cytogenet, 193(2) 2009, 86-92.
(PMID 19665068)
|
|
| aCGH: 111
|
Radtke I, Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z, Goorha S, et al.
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia.
Proc Natl Acad Sci U S A, 106(31) 2009, 12944-49.
(PMID 19651601)
|
|
| aCGH: 86
|
Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, et al.
Acquired copy number alterations in adult acute myeloid leukemia genomes.
Proc Natl Acad Sci U S A, 106(31) 2009, 12950-55.
(PMID 19651600)
|
|
| aCGH: 98
|
Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, et al.
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.
Blood, 114(13) 2009, 2688-98.
(PMID 19641190)
|
|
| aCGH: 2
|
Chen TT, Rakheja D, Hung JY, Hornsby PJ, Tabaczewski P, Malogolowkin M, Feusner J, et al.
Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.
Pediatr Blood Cancer, 2009.
(PMID 19637320)
|
|
| aCGH: 1
|
Adati N, Huang MC, Suzuki T, Suzuki H, and Kojima T.
High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line.
BMC Res Notes, 2(1) 2009, 153.
(PMID 19635138)
|
|
| aCGH: 39
|
Smeets SJ, Brakenhoff RH, Ylstra B, van Wieringen WN, van de Wiel MA, Leemans CR, et al.
Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis.
Cell Oncol, 31(4) 2009, 291-300.
(PMID 19633365)
|
|
| aCGH: 86
|
Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, and Lam WL.
Genomic imbalances in precancerous tissues signal oral cancer risk.
Mol Cancer, 8 2009, 50.
(PMID 19627613)
|
|
| aCGH: 222
|
Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, Tamura A, Honda H, et al.
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
Nature, 460(7257) 2009, 904-08.
(PMID 19620960)
|
|
| aCGH: 32
|
Osterberg L, Levan K, Partheen K, Staaf J, Sundfeldt K, and Horvath G.
High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
Cytogenet Genome Res, 125(1) 2009, 8-18.
(PMID 19617691)
|
|
| aCGH: 22
|
Rao SK, Edwards J, Joshi AD, Siu IM, and Riggins GJ.
A survey of glioblastoma genomic amplifications and deletions.
J Neurooncol, 2009.
(PMID 19609742)
|
|
| aCGH: 36
|
Kang JU, Koo SH, Kwon KC, Park JW, and Kim JM.
Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.
BMC Cancer, 9 2009, 237.
(PMID 19607727)
|
|
| aCGH: 27
|
Mantripragada KK, de Stahl TD, Patridge C, Menzel U, Andersson R, Chuzhanova N, et al.
Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array.
Genes Chromosomes Cancer, 48(10) 2009, 897-907.
(PMID 19603524)
|
|
| aCGH: 16
|
Yu W, Kanaan Y, Baed YK, and Gabrielson E.
Chromosomal changes in aggressive breast cancers with basal-like features.
Cancer Genet Cytogenet, 193(1) 2009, 29-37.
(PMID 19602461)
|
|
| CGH: 2
aCGH: 2
|
Balcarkova J, Urbankova H, Scudla V, Holzerova M, Bacovsky J, Indrak K, et al.
Gain of chromosome arm 1q in patients in relapse and progression of multiple myeloma.
Cancer Genet Cytogenet, 192(2) 2009, 68-72.
(PMID 19596256)
|
|
| aCGH: 25
|
Hameed M, Ulger C, Yasar D, Limaye N, Kurvathi R, Streck D, Benevenia J, Patterson F, et al.
Genome profiling of chondrosarcoma using oligonucleotide array-based comparative genomic hybridization.
Cancer Genet Cytogenet, 192(2) 2009, 56-59.
(PMID 19596254)
|
|
| aCGH: 67
|
Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, et al.
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.
Breast Cancer Res, 11(4) 2009, R47.
(PMID 19589159)
|
|
| aCGH: 50
|
Nakamura Y, Migita T, Hosoda F, Okada N, Gotoh M, Arai Y, Fukushima M, Ohki M, et al.
Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.
Int J Cancer, 2009.
(PMID 19588488)
|
|
| aCGH: 37
|
Lu Y, Ryan SL, Elliott DJ, Bignell GR, Futreal PA, Ellison DW, Bailey S, et al.
Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
PLoS One, 4(7) 2009, e6159.
(PMID 19584924)
|
|
| aCGH: 47
|
Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, Wang QH, Han XY, Giffen C, et al.
Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China.
Cancer Res, 69(14) 2009, 5908-17.
(PMID 19584285)
|
|
| aCGH: 3
|
Marella NV, Malyavantham KS, Wang J, Matsui S, Liang P, and Berezney R.
Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines.
Cancer Res, 69(14) 2009, 5946-53.
(PMID 19584277)
|
|
| aCGH: 52
|
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, et al.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
PLoS One, 4(7) 2009, e6146.
(PMID 19582160)
|
|
| aCGH: 1
|
Ying LS, Xu SH, Su D, Mou HZ, Gu LH, Zhu CH, and Liu XL.
[Study of the metastasis-associated genes and its copy numbers variation in highly metastatic epithelial ovarian cancer].
Zhonghua Fu Chan Ke Za Zhi, 44(2) 2009, 126-30.
(PMID 19570424)
|
|
| aCGH: 2
|
Buffart TE, Tijssen M, El-Bchiri J, Duval A, Wiel MA, Ylstra B, Meijer GA, et al.
NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.
BMC Med Genomics, 2 2009, 39.
(PMID 19563644)
|
|
| aCGH: 44
|
Goransson H, Edlund K, Rydaker M, Rasmussen M, Winquist J, Ekman S, Bergqvist M, et al.
Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data.
PLoS One, 4(6) 2009, e6057.
(PMID 19557126)
|
|
| aCGH: 1
|
Attard G, Rizzo S, Ledaki I, Clark J, Reid AH, Thompson A, Khoo V, de Bono JS, et al.
A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies.
Prostate, 69(14) 2009, 1507-20.
(PMID 19544327)
|
|
| aCGH: 46
|
Stejskalova E, Jarosova M, Malis J, Sumerauer D, Urbankova H, Krskova L, Pycha K, et al.
[Clinical relevance of chromosomal aberrations in bone and soft tissue tumors in children and young adults].
Klin Onkol, 22(2) 2009, 58-66.
(PMID 19522375)
|
|
| aCGH: 80
|
Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, et al.
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
Int J Cancer, 2009.
(PMID 19521957)
|
|
| aCGH: 40
|
Robledo C, Garcia JL, Caballero D, Conde E, Arranz R, Flores T, Grande C, et al.
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.
Cancer, 115(16) 2009, 3728-37.
(PMID 19517471)
|
|
| aCGH: 1
|
Lake A, Shield LA, Cordano P, Chui DT, Osborne J, Crae S, Wilson KS, Tosi S, et al.
Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
Int J Cancer, 125(6) 2009, 1334-42.
(PMID 19507254)
|
|
| aCGH: 9
|
Tosello V, Mansour MR, Barnes K, Paganin M, Sulis ML, Jenkinson S, Allen CG, Gale RE, et al.
WT1 mutations in T-ALL.
Blood, 114(5) 2009, 1038-45.
(PMID 19494353)
|
|
| aCGH: 2
|
Serio G, Gentile M, Pennella A, Marzullo A, Buonadonna AL, Nazzaro P, Testini M, et al.
Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac.
Pathol Int, 59(6) 2009, 415-21.
(PMID 19490474)
|
|
| aCGH: 52
|
Wilting SM, Smeets SJ, Snijders PJ, van Wieringen WN, van de Wiel MA, Meijer GA, et al.
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.
BMC Med Genomics, 2 2009, 32.
(PMID 19486517)
|
|
| aCGH: 7
|
Nakahata S, Saito Y, Hamasaki M, Hidaka T, Arai Y, Taki T, Taniwaki M, et al.
Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
Genes Chromosomes Cancer, 48(9) 2009, 768-76.
(PMID 19484761)
|
|
| aCGH: 102
|
Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M, et al.
Acquired mutations in TET2 are common in myelodysplastic syndromes.
Nat Genet, 41(7) 2009, 838-42.
(PMID 19483684)
|
|
| aCGH: 27
|
Usvasalo A, Raty R, Harila-Saari A, Koistinen P, Savolainen ER, Vettenranta K, et al.
Acute lymphoblastic leukemias with normal karyotypes are not without genomic aberrations.
Cancer Genet Cytogenet, 192(1) 2009, 10-17.
(PMID 19480931)
|
|
| aCGH: 5
|
Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, Kosmider O, et al.
Mutation in TET2 in myeloid cancers.
N Engl J Med, 360(22) 2009, 2289-301.
(PMID 19474426)
|
|
| CGH: 184
aCGH: 11
|
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, et al.
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
Blood, 114(4) 2009, 826-34.
(PMID 19471018)
|
|
| aCGH: 111
|
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, et al.
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Cancer Res, 69(11) 2009, 4674-81.
(PMID 19470766)
|
|
| aCGH: 47
|
Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, et al.
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Blood, 114(3) 2009, 647-50.
(PMID 19458356)
|
|
| aCGH: 43
|
Andersson E, Sward C, Stenman G, Ahlman H, and Nilsson O.
High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids.
Endocr Relat Cancer, 16(3) 2009, 953-66.
(PMID 19458023)
|
|
| aCGH: 1
|
Chiecchio L, Dagrada GP, Protheroe RK, Stockley DM, Smith AG, Orchard KH, Cross NC, et al.
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case.
Haematologica, 94(7) 2009, 1024-28.
(PMID 19454499)
|
|
| aCGH: 371
|
Sos ML, Michel K, Zander T, Weiss J, Frommolt P, Peifer M, Li D, Ullrich R, Koker M, et al.
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
J Clin Invest, 119(6) 2009, 1727-40.
(PMID 19451690)
|
|
| aCGH: 30
|
Kim M and Chung HC.
Standardized genetic alteration score and predicted score for predicting recurrence status of gastric cancer.
J Cancer Res Clin Oncol, 135(11) 2009, 1501-12.
(PMID 19449028)
|
|
| aCGH: 97
|
Yeh IT, Martin MA, Robetorye RS, Bolla AR, McCaskill C, Shah RK, Gorre ME, et al.
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event.
Mod Pathol, 22(9) 2009, 1169-75.
(PMID 19448591)
|
|
| aCGH: 72
|
Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, and Kovacs G.
High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.
BMC Cancer, 9 2009, 152.
(PMID 19445733)
|
|
| aCGH: 2
|
Li J, Gao F, Li N, Li S, Yin G, Tian G, Jia S, Wang K, Zhang X, Yang H, Nielsen AL, et al.
An improved method for genome wide DNA methylation profiling correlated to transcription and genomic instability in two breast cancer cell lines.
BMC Genomics, 10 2009, 223.
(PMID 19439076)
|
|
| aCGH: 61
|
Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, et al.
High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Mol Cancer Res, 7(5) 2009, 665-77.
(PMID 19435819)
|
|
| CGH: 1
aCGH: 1
|
Chuang SS, Liao YL, Liou CP, Wiggins ML, Ye H, Du MQ, Isaacson PG, et al.
Chronic lymphocytic leukemia with paraimmunoblastic transformation - with comparative genomic hybridization and review of the literature.
Pathol Res Pract, 2009.
(PMID 19433347)
|
|
| aCGH: 6
|
Muggerud AA, Edgren H, Wolf M, Kleivi K, Dejeux E, Tost J, Sorlie T, et al.
Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line.
BMC Med Genomics, 2 2009, 26.
(PMID 19432969)
|
|
| aCGH: 2
|
Zimonjic DB, Zhou X, Lee JS, Ullmannova-Benson V, Tripathi V, Thorgeirsson SS, et al.
Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line.
J Cell Mol Med, 2009.
(PMID 19426152)
|
|
| aCGH: 57
|
Haverty PM, Hon LS, Kaminker JS, Chant J, and Zhang Z.
High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors.
BMC Med Genomics, 2 2009, 21.
(PMID 19419571)
|
|
| aCGH: 98
|
Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, et al.
Chromosomal instability and copy number alterations in Barretts esophagus and esophageal adenocarcinoma.
Clin Cancer Res, 15(10) 2009, 3305-14.
(PMID 19417022)
|
|
| aCGH: 12
|
Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, Bertoni F, Ponzoni M, et al.
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
Nature, 459(7247) 2009, 717-21.
(PMID 19412164)
|
|
| aCGH: 238
|
Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, et al.
Frequent inactivation of A20 in B-cell lymphomas.
Nature, 459(7247) 2009, 712-16.
(PMID 19412163)
|
|
| aCGH: 73
|
Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A, Werft W, Breit S, Liu S, et al.
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for . . .
Blood, 114(5) 2009, 1053-62.
(PMID 19406988)
|
|
| aCGH: 78
|
Chapiro E, Leporrier N, Radford-Weiss I, Bastard C, Mossafa H, Leroux D, Tigaud I, et al.
Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.
Leuk Res, 2009.
(PMID 19406473)
|
|
| aCGH: 59
|
Sircar K, Yoshimoto M, Monzon FA, Koumakpayi IH, Katz RL, Khanna A, Alvarez K, et al.
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.
J Pathol, 218(4) 2009, 505-13.
(PMID 19402094)
|
|
| aCGH: 45
|
Agnelli L, Mosca L, Fabris S, Lionetti M, Andronache A, Kwee I, Todoerti K, et al.
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
Genes Chromosomes Cancer, 48(7) 2009, 603-14.
(PMID 19396863)
|
|
| aCGH: 39
|
Nicolet C, Guerin E, Neuville A, Kerckaert JP, Wicker N, Bergmann E, Brigand C, et al.
Evidence for various 20q status using allelotyping, CGH arrays, and quantitative PCR in distal CIN colon cancers.
Cancer Lett, 282(2) 2009, 195-204.
(PMID 19394760)
|
|
| aCGH: 18
|
Sevilla MA, Hermsen MA, Weiss MM, Grimbergen A, Balbin M, Llorente JL, Rodrigo JP, et al.
Chromosomal changes in sporadic and familial head and neck paragangliomas.
Otolaryngol Head Neck Surg, 140(5) 2009, 724-29.
(PMID 19393419)
|
|
| aCGH: 19
|
Schraders M, van Reijmersdal SV, Kamping EJ, van Krieken JH, van Kessel AG, et al.
High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
Cancer Genet Cytogenet, 191(1) 2009, 27-33.
(PMID 19389505)
|
|
| aCGH: 172
|
Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerod A, Han W, Noh DY, et al.
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.
Mol Oncol, 2(4) 2008, 327-39.
(PMID 19383354)
|
|
| aCGH: 54
|
Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G, et al.
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
J Exp Med, 206(5) 2009, 981-89.
(PMID 19380639)
|
|
| aCGH: 4
|
Rieber J, Remke M, Hartmann C, Korshunov A, Burkhardt B, Sturm D, Mechtersheimer G, et al.
Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
Genes Chromosomes Cancer, 48(7) 2009, 558-68.
(PMID 19378321)
|
|
| aCGH: 50
|
Forshew T, Tatevossian RG, Lawson AR, Ma J, Neale G, Ogunkolade BW, Jones TA, et al.
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.
J Pathol, 218(2) 2009, 172-81.
(PMID 19373855)
|
|
| aCGH: 51
|
Hu X, Stern HM, Ge L, OBrien C, Haydu L, Honchell CD, Haverty PM, Peters BA, Wu TD, et al.
Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
Mol Cancer Res, 7(4) 2009, 511-22.
(PMID 19372580)
|
|
| aCGH: 35
|
Crowder RJ, Phommaly C, Tao Y, Hoog J, Luo J, Perou CM, Parker JS, Miller MA, et al.
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
Cancer Res, 69(9) 2009, 3955-62.
(PMID 19366795)
|
|
| aCGH: 74
|
Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, et al.
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
Nat Med, 15(5) 2009, 559-65.
(PMID 19363497)
|
|
| aCGH: 42
|
Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R, Schop RF, et al.
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstroms macroglobulinemia.
Cancer Res, 69(8) 2009, 3579-88.
(PMID 19351844)
|
|
| aCGH: 313
|
Zhang Y, Martens JW, Yu JX, Jiang J, Sieuwerts AM, Smid M, Klijn JG, Wang Y, et al.
Copy number alterations that predict metastatic capability of human breast cancer.
Cancer Res, 69(9) 2009, 3795-801.
(PMID 19336569)
|
|
| aCGH: 67
|
Hallor KH, Staaf J, Bovee JV, Hogendoorn PC, Cleton-Jansen AM, Knuutila S, Savola S, et al.
Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
Clin Cancer Res, 15(8) 2009, 2685-94.
(PMID 19336518)
|
|
| aCGH: 18
|
Kwek SS, Roy R, Zhou H, Climent J, Martinez-Climent JA, Fridlyand J, et al.
Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
Oncogene, 28(17) 2009, 1892-903.
(PMID 19330026)
|
|
| aCGH: 34
|
Boelens MC, Kok K, van der Vlies P, van der Vries G, Sietsma H, Timens W, Postma DS, et al.
Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
Lung Cancer, 66(3) 2009, 372-78.
(PMID 19324446)
|
|
| aCGH: 95
|
Natrajan R, Lambros MB, Rodriguez-Pinilla SM, Moreno-Bueno G, Tan DS, Marchio C, et al.
Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
Clin Cancer Res, 15(8) 2009, 2711-22.
(PMID 19318498)
|
|
| aCGH: 12
|
Zatkova A, Merk S, Wendehack M, Bilban M, Muzik EM, Muradyan A, Haferlach C, et al.
AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
Genes Chromosomes Cancer, 48(6) 2009, 510-20.
(PMID 19306356)
|
|
| aCGH: 12
|
Tan DS, Lambros MB, Rayter S, Natrajan R, Vatcheva R, Gao Q, Marchio C, Geyer FC, et al.
PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas.
Clin Cancer Res, 2009.
(PMID 19293255)
|
|
| aCGH: 49
|
Carneiro A, Francis P, Bendahl PO, Fernebro J, Akerman M, Fletcher C, Rydholm A, et al.
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
Lab Invest, 89(6) 2009, 668-75.
(PMID 19290004)
|
|
| aCGH: 21
|
Chan MW, Hui AB, Yip SK, Ng CF, Lo KW, Tong JH, Chan AW, Cheung HY, Wong WS, Chan PS, et al.
Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.
Int J Oncol, 34(4) 2009, 963-70.
(PMID 19287953)
|
|
| aCGH: 236
|
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al.
High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma.
Int J Oncol, 34(4) 2009, 931-38.
(PMID 19287950)
|
|
| aCGH: 10
|
Sadikovic B, Yoshimoto M, Chilton-MacNeill S, Thorner P, Squire JA, et al.
Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.
Hum Mol Genet, 18(11) 2009, 1962-75.
(PMID 19286668)
|
|
| aCGH: 86
|
Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC, Robetorye RS, et al.
Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
Blood, 113(26) 2009, 6681-90.
(PMID 19278952)
|
|
| aCGH: 184
|
Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, et al.
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.
Cancer Biol Ther, 8(10) 2009.
(PMID 19276661)
|
|
| aCGH: 212
|
Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, et al.
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.
Nat Genet, 41(4) 2009, 465-72.
(PMID 19270706)
|
|
| aCGH: 20
|
Watson SK, Woolcock BW, Fee JN, Bainbridge TC, Webber D, Kinahan TJ, Lam WL, et al.
Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
Prostate, 2009.
(PMID 19267368)
|
|
| aCGH: 57
|
Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, Raeder MB, et al.
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proc Natl Acad Sci U S A, 106(12) 2009, 4834-39.
(PMID 19261849)
|
|
| aCGH: 32
|
Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, et al.
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Blood, 113(20) 2009, 4918-21.
(PMID 19258598)
|
|
| aCGH: 21
|
Fritz S, Fernandez-del Castillo C, Mino-Kenudson M, Crippa S, Deshpande V, Lauwers GY, et al.
Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.
Ann Surg, 249(3) 2009, 440-47.
(PMID 19247032)
|
|
| aCGH: 20
|
Castro P, Creighton CJ, Ozen M, Berel D, Mims MP, and Ittmann M.
Genomic profiling of prostate cancers from African American men.
Neoplasia, 11(3) 2009, 305-12.
(PMID 19242612)
|
|
| aCGH: 13
|
Missiaglia E, Selfe J, Hamdi M, Williamson D, Schaaf G, Fang C, Koster J, et al.
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor . . .
Genes Chromosomes Cancer, 2009.
(PMID 19235922)
|
|
| aCGH: 93
|
Wang Y, Carlton VE, Karlin-Neumann G, Sapolsky R, Zhang L, Moorhead M, Wang ZC, et al.
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays.
BMC Med Genomics, 2 2009, 8.
(PMID 19228381)
|
|
| aCGH: 24
|
Saito S, Morita K, and Hirano T.
High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell . . .
Hum Cell, 22(1) 2009, 1-10.
(PMID 19222606)
|
|
| aCGH: 5
|
Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HC, Astrom K, Domanski HA, et al.
Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar . . .
J Pathol, 217(5) 2009, 716-27.
(PMID 19199331)
|
|
| aCGH: 15
|
Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, Klinkebiel D, Christman JK, et al.
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
Leukemia, 2009.
(PMID 19194464)
|
|
| aCGH: 118
|
Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, Getz G, Tothill R, et al.
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
Clin Cancer Res, 15(4) 2009, 1417-27.
(PMID 19193619)
|
|
| aCGH: 4
|
Christgen M, Bruchhardt H, Hadamitzky C, Rudolph C, Steinemann D, Gadzicki D, et al.
Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer.
J Pathol, 217(5) 2009, 620-32.
(PMID 19191266)
|
|
| aCGH: 2
|
Guo J, Anderson MG, Tapang P, Palma JP, Rodriguez LE, Niquette A, Li J, Bouska JJ, et al.
Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152.
Pharmacogenomics J, 9(2) 2009, 90-102.
(PMID 19188929)
|
|
| aCGH: 4
|
Buys TP, Aviel-Ronen S, Waddell TK, Lam WL, and Tsao MS.
Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
J Thorac Oncol, 4(2) 2009, 227-39.
(PMID 19179901)
|
|
| aCGH: 1
|
Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, Arentsen-Peters ST, et al.
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
Blood, 2009.
(PMID 19171881)
|
|
| aCGH: 423
|
Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, et al.
Overall genomic pattern is a predictor of outcome in neuroblastoma.
J Clin Oncol, 27(7) 2009, 1026-33.
(PMID 19171713)
|
|
| aCGH: 9
|
Jardin F, Callanan M, Penther D, Ruminy P, Troussard X, Kerckaert JP, Figeac M, et al.
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the . . .
Leukemia, 2009.
(PMID 19158833)
|
|
| aCGH: 93
|
Natrajan R, Lambros MB, Geyer FC, Marchio C, Tan DS, Vatcheva R, Shiu KK, et al.
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
Genes Chromosomes Cancer, 48(4) 2009, 351-65.
(PMID 19156836)
|
|
| aCGH: 36
|
van Nederveen F, Korpershoek E, Deleeuw R, Verhofstad AA, Lenders JW, Dinjens W, et al.
Array-CGH in sporadic benign pheochromocytomas.
Endocr Relat Cancer, 2009.
(PMID 19153209)
|
|
| aCGH: 8
|
Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, Alvarez S, Yokota J, et al.
The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
Hum Mol Genet, 18(7) 2009, 1343-52.
(PMID 19153074)
|
|
| aCGH: 106
|
Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, et al.
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Clin Cancer Res, 15(2) 2009, 441-51.
(PMID 19147748)
|
|
| aCGH: 46
|
Wilting SM, Steenbergen RD, Tijssen M, van Wieringen WN, Helmerhorst TJ, et al.
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
Cancer Res, 69(2) 2009, 647-55.
(PMID 19147580)
|
|
| aCGH: 21
|
Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, et al.
Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
Neuro Oncol, 11(5) 2009, 477-87.
(PMID 19139420)
|
|
| aCGH: 23
|
Tsui IF, Rosin MP, Zhang L, Ng RT, and Lam WL.
Multiple aberrations of chromosome 3p detected in oral premalignant lesions.
Cancer Prev Res (Phila Pa), 1(6) 2008, 424-29.
(PMID 19138989)
|
|
| aCGH: 61
|
Nakagawa M, Nakagawa-Oshiro A, Karnan S, Tagawa H, Utsunomiya A, Nakamura S, et al.
Array Comparative Genomic Hybridization Analysis of PTCL-U Reveals a Distinct Subgroup with Genetic Alterations Similar to Lymphoma-Type Adult T-Cell Leukemia/Lymphoma.
Clin Cancer Res, 15(1) 2009, 30-38.
(PMID 19118030)
|
|
| aCGH: 8
|
Kubo T, Yamamoto H, Lockwood WW, Valencia I, Soh J, Peyton M, Jida M, Otani H, et al.
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.
Int J Cancer, 2008.
(PMID 19117057)
|
|
| aCGH: 39
|
Coss A, Tosetto M, Fox EJ, Sapetto-Rebow B, Gorman S, Kennedy BN, Lloyd AT, Hyland JM, et al.
Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis.
Cancer Lett, 2008.
(PMID 19111388)
|
|
| aCGH: 7
|
Lennon PA, Zhuang Y, Pierson D, Zhang X, Williams C, Perez C, et al.
Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple . . .
Cancer, 2008.
(PMID 19109814)
|
|
| aCGH: 47
|
Akagi T, Shih LY, Kato M, Kawamata N, Yamamoto G, Sanada M, Okamoto R, Miller CW, et al.
Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.
Blood, 113(8) 2009, 1741-48.
(PMID 19109227)
|
|
| aCGH: 13
|
Bentley J, Lhote C, Platt F, Hurst CD, Lowery J, Taylor C, Sak SC, Harnden P, et al.
Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.
Genes Chromosomes Cancer, 2008.
(PMID 19105236)
|
|
| aCGH: 77
|
Nakao M, Kawauchi S, Furuya T, Uchiyama T, Adachi J, Okada T, Ikemoto K, Oga A, et al.
Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles.
Cancer Genet Cytogenet, 188(2) 2009, 70-76.
(PMID 19100508)
|
|
| aCGH: 42
|
Chochi Y, Kawauchi S, Nakao M, Furuya T, Hashimoto K, Oga A, Oka M, et al.
A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
J Pathol, 2008.
(PMID 19097070)
|
|
| aCGH: 14
|
Kuijper A, Snijders AM, Berns EM, Kuenen-Boumeester V, van der Wall E, Albertson DG, et al.
Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.
Cell Oncol, 31(1) 2009, 31-39.
(PMID 19096148)
|
|
| aCGH: 145
|
Balleine RL, Webster LR, Davis S, Salisbury EL, Palazzo JP, Schwartz GF, Cornfield DB, et al.
Molecular grading of ductal carcinoma in situ of the breast.
Clin Cancer Res, 14(24) 2008, 8244-52.
(PMID 19088042)
|
|
| aCGH: 5
|
Zhang X, Zhu ZH, Lin P, Yang H, Fu JH, Zhang LJ, Long H, Wen J, Huang XP, Fang Y, et al.
[Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K SNP array.].
Zhonghua Yi Xue Za Zhi, 88(37) 2008, 2636-41.
(PMID 19080713)
|
|
| aCGH: 29
|
Harada T, Chelala C, Crnogorac-Jurcevic T, and Lemoine NR.
Genome-Wide Analysis of Pancreatic Cancer Using Microarray-Based Techniques.
Pancreatology, 9(1-2) 2008, 13-24.
(PMID 19077451)
|
|
| aCGH: 58
|
Solomon DA, Kim JS, Cronin JC, Sibenaller Z, Ryken T, Rosenberg SA, Ressom H, Jean W, et al.
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.
Cancer Res, 68(24) 2008, 10300-06.
(PMID 19074898)
|
|
| aCGH: 100
|
Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, Wierda WG, et al.
Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia.
J Mol Diagn, 11(1) 2009, 25-34.
(PMID 19074592)
|
|
| aCGH: 24
|
Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard CA, Goga A, et al.
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.
Cancer Cell, 14(6) 2008, 471-84.
(PMID 19061838)
|
|
| aCGH: 160
|
Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, et al.
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.
Cancer Cell, 14(6) 2008, 435-46.
(PMID 19061835)
|
|
| aCGH: 1
|
Pfister S, Remke M, Castoldi M, Bai AH, Muckenthaler MU, Kulozik A, von Deimling A, et al.
Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes.
Acta Neuropathol, 117(4) 2009, 457-64.
(PMID 19057917)
|
|
| aCGH: 42
|
Oudejans JJ, van Wieringen WN, Smeets SJ, Tijssen M, Vosse SJ, Meijer CJ, Meijer GA, et al.
Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
Genes Chromosomes Cancer, 48(3) 2009, 250-60.
(PMID 19051311)
|
|
| CGH: 8
aCGH: 23
|
Paulson KG, Lemos BD, Feng B, Jaimes N, Peñas PF, Bi X, Maher E, Cohen L, Leonard JH, et al.
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc.
J. Invest. Dermatol, 2008, .
(PMID 19020549)
|
|
| aCGH: 44
|
Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K, et al.
Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.
Cancer Res, 68(21) 2008, 8673-77.
(PMID 18974108)
|
|
| aCGH: 45
|
McCabe MG, Ichimura K, Pearson DM, Liu L, Clifford SC, Ellison DW, et al.
Novel mechanisms of gene disruption at the medulloblastoma isodicentric 17p11 breakpoint.
Genes Chromosomes Cancer, 48(2) 2009, 121-31.
(PMID 18973140)
|
|
| aCGH: 10
|
Sugimoto T, Seki N, Shimizu S, Kikkawa N, Tsukada J, Shimada H, Sasaki K, Hanazawa T, et al.
The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma.
Genes Chromosomes Cancer, 48(2) 2009, 132-42.
(PMID 18973137)
|
|
| aCGH: 79
|
Lips EH, van Eijk R, de Graaf EJ, Oosting J, de Miranda NF, Karsten T, et al.
Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
BMC Cancer, 8 2008, 314.
(PMID 18959792)
|
|
| aCGH: 71
|
Tefferi A, Sirhan S, Sun Y, Lasho T, Finke CM, Weisberger J, Bale S, Compton J, et al.
Oligonucleotide array CGH studies in myeloproliferative neoplasms: Comparison with JAK2V617F mutational status and conventional chromosome analysis.
Leuk Res, 2008.
(PMID 18937974)
|
|
| aCGH: 10
|
Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, Bayani J, Thorner P, Maire G, et al.
Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
Cytogenet Genome Res, 122(1) 2008, 5-15.
(PMID 18931480)
|
|
| aCGH: 214
|
Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, et al.
Oncogenic mutations of ALK kinase in neuroblastoma.
Nature, 455(7215) 2008, 971-74.
(PMID 18923524)
|
|
| aCGH: 1
|
Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, et al.
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Nature, 455(7215) 2008, 967-70.
(PMID 18923523)
|
|
| aCGH: 58
|
Grubor V, Krasnitz A, Troge JE, Meth JL, Lakshmi B, Kendall JT, Yamrom B, Alex G, et al.
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA).
Blood, 2008.
(PMID 18922857)
|
|
| aCGH: 82
|
Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, et al.
Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
Gut, 58(1) 2009, 79-89.
(PMID 18829976)
|
|
| aCGH: 19
|
de Tayrac M, Etcheverry A, Aubry M, Saikali S, Hamlat A, Quillien V, Le Treut A, et al.
Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
Genes Chromosomes Cancer, 48(1) 2009, 55-68.
(PMID 18828157)
|
|
| aCGH: 128
|
Schwaenen C, Viardot A, Berger H, Barth TF, Bentink S, Dohner H, Enz M, Feller AC, et al.
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status.
Genes Chromosomes Cancer, 48(1) 2009, 39-54.
(PMID 18828156)
|
|
| aCGH: 56
|
Lundgren K, Holm K, Nordenskjold B, Borg A, and Landberg G.
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Breast Cancer Res, 10(5) 2008, R81.
(PMID 18823530)
|
|
| CGH: 117
aCGH: 4
|
Bauer VL, Braselmann H, Henke M, Mattern D, Walch A, Unger K, Baudis M, Lassmann S, et al.
Chromosomal changes characterize head and neck cancer with poor prognosis.
J. Mol. Med, 2008, .
(PMID 18810378)
|
|
| aCGH: 29
|
Bungaro S, DellOrto MC, Zangrando A, Basso D, Gorletta T, Lo Nigro L, Leszl A, et al.
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks.
Genes Chromosomes Cancer, 48(1) 2009, 22-38.
(PMID 18803328)
|
|
| aCGH: 474
|
Staaf J, Lindgren D, Vallon-Christersson J, Isaksson A, Goransson H, Juliusson G, et al.
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays.
Genome Biol, 9(9) 2008, R136.
(PMID 18796136)
|
|
| aCGH: 20
|
Koeman JM, Russell RC, Tan MH, Petillo D, Westphal M, Koelzer K, Metcalf JL, Zhang Z, et al.
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated ELGN2-mediated oxygen-sensing response.
PLoS Genet, 4(9) 2008, e1000176.
(PMID 18773095)
|
|
| aCGH: 223
|
McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Marie Mastrogianakis G, et al.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Nature, 2008.
(PMID 18772890)
|
|
| aCGH: 1
|
Deluche L, Joha S, Corm S, Daudignon A, Geffroy S, Quief S, Villenet C, Kerckaert JP, et al.
Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: A complex chromosomal rearrangement . . .
Genes Chromosomes Cancer, 2008.
(PMID 18767145)
|
|
| aCGH: 203
|
Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, et al.
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
Proc Natl Acad Sci U S A, 105(36) 2008, 13520-25.
(PMID 18765795)
|
|
| aCGH: 58
|
Bilke S, Chen QR, Wei JS, and Khan J.
Whole Chromosome Alterations Predict Survival in High-Risk Neuroblastoma without MYCN Amplification.
Clin Cancer Res, 14(17) 2008, 5540-47.
(PMID 18765546)
|
|
| aCGH: 51
|
Arai E, Ushijima S, Tsuda H, Fujimoto H, Hosoda F, Shibata T, Kondo T, Imoto I, et al.
Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient . . .
Clin Cancer Res, 14(17) 2008, 5531-39.
(PMID 18765545)
|
|
| aCGH: 30
|
Ye L, Santarpia L, Cote GJ, El-Naggar AK, and Gagel RF.
High Resolution Array-Comparative Genomic Hybridization Profiling Reveals DNA Copy Number Alterations associated with Medullary Thyroid Carcinoma.
J Clin Endocrinol Metab, 2008.
(PMID 18765511)
|
|
| aCGH: 152
|
Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, et al.
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Cancer Res, 68(17) 2008, 7165-75.
(PMID 18757432)
|
|
| aCGH: 8
|
Mhawech-Fauceglia P, Odunsi K, Dim D, Nowak N, Lele S, Cheney RT, et al.
Array-Comparative Genomic Hybridization Analysis of Primary Endometrial and Ovarian High-grade Neuroendocrine Carcinoma Associated With Adenocarcinoma: Mystery Resolved?
Int J Gynecol Pathol, 2008.
(PMID 18753966)
|
|
| aCGH: 36
|
Lee JJ, Au AY, Foukakis T, Barbaro M, Kiss N, Clifton-Bligh R, Staaf J, Borg A, et al.
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
Endocr Relat Cancer, 15(3) 2008, 801-15.
(PMID 18753363)
|
|
| aCGH: 40
|
Booman M, Szuhai K, Rosenwald A, Hartmann E, Kluin-Nelemans H, De Jong D, et al.
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
J Pathol, 216(2) 2008, 209-17.
(PMID 18729069)
|
|
| aCGH: 38
|
Poonepalli A, Banerjee B, Ramnarayanan K, Palanisamy N, Putti TC, et al.
Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Genes Chromosomes Cancer, 2008.
(PMID 18720522)
|
|
| aCGH: 130
|
Joosse SA, van Beers EH, Tielen IH, Horlings H, Peterse JL, Hoogerbrugge N, et al.
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
Breast Cancer Res Treat, 2008.
(PMID 18704682)
|
|
| aCGH: 10
|
Min HS, Kim B, and Park SH.
Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri.
J Neurooncol, 2008.
(PMID 18704270)
|
|
| aCGH: 106
|
Cheung KJ, Shah SP, Steidl C, Johnson N, Relander T, Telenius A, Lai B, Murphy KP, et al.
Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.
Blood, 2008.
(PMID 18703704)
|
|
| aCGH: 91
|
Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, et al.
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer Res, 68(16) 2008, 6779-88.
(PMID 18701503)
|
|
| aCGH: 2
|
Sadikovic B, Yoshimoto M, Al-Romaih K, Maire G, Zielenska M, et al.
In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma.
PLoS ONE, 3(7) 2008, e2834.
(PMID 18698372)
|
|
| CGH: 53
aCGH: 3
|
Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, and El-Naggar AK.
Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands.
Clin Cancer Res, 14(16) 2008, 5181-87.
(PMID 18698036)
|
|
| aCGH: 14
|
Kuga D, Mizoguchi M, Guan Y, Hata N, Yoshimoto K, Shono T, Suzuki SO, Kukita Y, et al.
Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues.
Neuro-Oncology, 10(6) 2008, 995-1003.
(PMID 18697953)
|
|
| aCGH: 174
|
Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, Preobrazhensky SN, et al.
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.
J Mol Diagn, 10(5) 2008, 442-51.
(PMID 18687794)
|
|
| aCGH: 94
|
Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, Abecassis J, et al.
Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.
Oncogene, 2008.
(PMID 18679425)
|
|
| aCGH: 4
|
Giefing M, Arnemann J, Martin-Subero JI, Nielander I, Bug S, Hartmann S, Arnold N, et al.
Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell . . .
Br J Haematol, 2008.
(PMID 18671701)
|
|
| aCGH: 83
|
Liu W, Xie CC, Zhu Y, Li T, Sun J, Cheng Y, Ewing CM, Dalrymple S, Turner AR, Sun J, et al.
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.
Neoplasia, 10(8) 2008, 897-907.
(PMID 18670647)
|
|
| aCGH: 38
banding: 1 |
Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K, Brooks-Wilson A, et al.
High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall . . .
Blood, 2008.
(PMID 18663149)
|
|
| aCGH: 1
|
Xu W, Lu X, Kim Y, Luo Y, Martin M, Mulvihill JJ, and Li S.
Deletion of 14q24.1 approximately q24.3 in a patient with acute lymphoblastic leukemia: a hidden chromosomal anomaly detected by array-based comparative genomic . . .
Cancer Genet Cytogenet, 185(1) 2008, 43-46.
(PMID 18656693)
|
|
| aCGH: 1
banding: 1 |
Baeumler J, Szuhai K, Falkenburg JH, van Schie ML, Ottmann OG, et al.
Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement.
Cancer Genet Cytogenet, 185(1) 2008, 37-42.
(PMID 18656692)
|
|
| aCGH: 4
|
Horbinski C, Dacic S, McLendon RE, Cieply K, Datto M, Brat DJ, et al.
Chordoid Glioma: A Case Report and Molecular Characterization of Five Cases.
Brain Pathol, 2008.
(PMID 18652591)
|
|
| aCGH: 62
|
Hwang KT, Han W, Cho J, Lee JW, Ko E, Kim EK, Jung SY, Jeong EM, Bae JY, Kang JJ, et al.
Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer.
Int J Cancer, 123(8) 2008, 1807-15.
(PMID 18649361)
|
|
| aCGH: 46
|
Dib A, Gabrea A, Glebov OK, Bergsagel PL, and Kuehl WM.
Characterization of MYC translocations in multiple myeloma cell lines.
J Natl Cancer Inst Monogr, (39) 2008, 25-31.
(PMID 18647998)
|
|
| aCGH: 18
|
Mhawech-Fauceglia P, Rai H, Nowak N, Cheney RT, Rodabaugh K, Lele S, et al.
The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus.
Histopathology, 2008.
(PMID 18643851)
|
|
| aCGH: 29
|
Aviel-Ronen S, Coe BP, Lau SK, da Cunha Santos G, Zhu CQ, Strumpf D, Jurisica I, et al.
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features.
Proc Natl Acad Sci U S A, 105(29) 2008, 10155-60.
(PMID 18632575)
|
|
| aCGH: 38
|
Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, et al.
Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Clin Cancer Res, 14(14) 2008, 4446-54.
(PMID 18628458)
|
|
| aCGH: 1
banding: 1 |
Krupp W, Holland H, Koschny R, Bauer M, Schober R, Kirsten H, Livrea M, et al.
Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics.
Cancer Genet Cytogenet, 184(2) 2008, 87-93.
(PMID 18617056)
|
|
| aCGH: 33
|
Brommesson S, Jonsson G, Strand C, Grabau D, Malmstrom P, Ringner M, Ferno M, et al.
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.
BMC Clin Pathol, 8 2008, 6.
(PMID 18616792)
|
|
| aCGH: 5
|
Hallor KH, Teixeira MR, Fletcher CD, Bizarro S, Staaf J, Domanski HA, von Steyern FV, et al.
Heterogeneous genetic profiles in soft tissue myoepitheliomas.
Mod Pathol, 21(11) 2008, 1311-19.
(PMID 18604193)
|
|
| aCGH: 24
|
Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, et al.
Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
Cancer Res, 68(13) 2008, 5067-75.
(PMID 18593905)
|
|
| aCGH: 94
|
Kurashina K, Yamashita Y, Ueno T, Koinuma K, Ohashi J, Horie H, Miyakura Y, Hamada T, et al.
Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma.
Cancer Sci, 99(9) 2008, 1835-40.
(PMID 18564138)
|
|
| aCGH: 3
|
Giefing M, Martin-Subero JI, Kiwerska K, Jarmuz M, Grenman R, Siebert R, et al.
Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines.
Cancer Genet Cytogenet, 184(1) 2008, 38-43.
(PMID 18558287)
|
|
| aCGH: 32
banding: 29 |
Lo KC, Chalker J, Strehl S, Neat M, Smith O, Dastugue N, Kearney L, Izraeli S, et al.
Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
Br J Haematol, 2008.
(PMID 18557744)
|
|
| aCGH: 65
|
Fix A, Lucchesi C, Ribeiro A, Lequin D, Pierron G, Schleiermacher G, Delattre O, et al.
Characterization of amplicons in neuroblastoma: high-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes.
Genes Chromosomes Cancer, 47(10) 2008, 819-34.
(PMID 18553563)
|
|
| CGH: 1
aCGH: 1
|
Kowalska A, Brunner B, Bozsaky E, Chen QR, Stock C, Lorch T, Khan J, et al.
Sequence based high resolution chromosomal CGH.
Cytogenet Genome Res, 121(1) 2008, 1-6.
(PMID 18544918)
|
|
| aCGH: 7
|
Kresse SH, Skarn M, Ohnstad HO, Namlos HM, Bjerkehagen B, Myklebost O, et al.
DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
Mol Cancer, 7 2008, 48.
(PMID 18522746)
|
|
| aCGH: 18
|
Fabris S, Mosca L, Todoerti K, Cutrona G, Lionetti M, Intini D, Matis S, Colombo M, et al.
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Genes Chromosomes Cancer, 47(9) 2008, 781-93.
(PMID 18521849)
|
|
| aCGH: 23
|
Nancarrow DJ, Handoko HY, Smithers BM, Gotley DC, Drew PA, Watson DI, Clouston AD, et al.
Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays.
Cancer Res, 68(11) 2008, 4163-72.
(PMID 18519675)
|
|
| aCGH: 1
banding: 1 |
Bostrom H, Leuchowius KJ, Hallbook H, Nordgren A, Thorn I, Thorselius M, et al.
U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
Eur J Haematol, 2008.
(PMID 18510704)
|
|
| aCGH: 454
|
Gupta M, Raghavan M, Gale RE, Chelala C, Allen C, Molloy G, Chaplin T, Linch DC, et al.
Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia.
Genes Chromosomes Cancer, 47(9) 2008, 729-39.
(PMID 18506749)
|
|
| aCGH: 100
|
Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, et al.
Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.
Genes Chromosomes Cancer, 47(9) 2008, 755-65.
(PMID 18506748)
|
|
| aCGH: 38
|
Myllykangas S, Junnila S, Kokkola A, Autio R, Scheinin I, Kiviluoto T, et al.
Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes.
Int J Cancer, 123(4) 2008, 817-25.
(PMID 18506690)
|
|
| aCGH: 50
|
Bertucci F, Orsetti B, Negre V, Finetti P, Rouge C, Ahomadegbe JC, Bibeau F, et al.
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.
Oncogene, 2008.
(PMID 18490921)
|
|
| aCGH: 54
|
Raghavan M, Smith LL, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, et al.
Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia.
Blood, 112(3) 2008, 814-21.
(PMID 18490517)
|
|
| aCGH: 45
banding: 44 |
Paulsson K, Cazier J-B, Macdougall F, Stevens J, Stasevich I, Vrcelj N, Chaplin T, et al.
Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.
Proceedings of the National Academy of Sciences of the United States of America, 105(18) 2008, 6708-13.
(PMID 18458336)
|
|
| aCGH: 109
|
Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu C-G, Giannakakis A, et al.
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America, 105(19) 2008, 7004-09.
(PMID 18458333)
|
|
| aCGH: 178
|
Kujawski L, Ouillette P, Erba H, Saddler C, Jakubowiak A, Kaminski M, Shedden K, et al.
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Blood, 2008, .
(PMID 18436738)
|
|
| aCGH: 24
|
Greshock J, Cheng J, Rusnak D, Martin AM, Wooster R, Gilmer T, Lee K, Weber BL, et al.
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines.
Mol Cancer Ther, 7(4) 2008, 935-43.
(PMID 18413807)
|
|
| aCGH: 20
|
Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC, et al.
Novel and highly recurrent chromosomal alterations in Sezary syndrome.
Cancer Res, 68(8) 2008, 2689-98.
(PMID 18413736)
|
|
| aCGH: 10
|
Deshmukh H, Yeh TH, Yu J, Sharma MK, Perry A, Leonard JR, Watson MA, Gutmann DH, et al.
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas.
Oncogene, 2008.
(PMID 18408760)
|
|
| aCGH: 33
|
Unger K, Malisch E, Thomas G, Braselmann H, Walch A, Jackl G, Lewis P, Lengfelder E, et al.
Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC.
Oncogene, 2008.
(PMID 18408749)
|
|
| aCGH: 252
|
Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, et al.
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Nature, 453(7191) 2008, 110-14.
(PMID 18408710)
|
|
| aCGH: 13
|
Guled M, Myllykangas S, Frierson H, Mills S, Knuutila S, and Stelow E.
Array comparative genomic hybridization analysis of olfactory neuroblastoma.
Mod pathology, 2008, .
(PMID 18408657)
|
|
| CGH: 13
aCGH: 13
|
Rassekh SR, Chan S, Harvard C, Dix D, Qiao Y, and Rajcan-Separovic E.
Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
Cancer Genet Cytogenet, 182(2) 2008, 84-94.
(PMID 18406869)
|
|
| aCGH: 16
|
Argos M, Kibriya MG, Jasmine F, Olopade OI, Su T, Hibshoosh H, et al.
Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
Cancer Genet Cytogenet, 182(2) 2008, 69-74.
(PMID 18406867)
|
|
| aCGH: 30
|
Carneiro A, Isinger A, Karlsson A, Johansson J, Jonnsson G, Bendahl P, Falkenbach D, et al.
Prognostic Impact of Array-based Genomic Profiles in Esophageal Squamous Cell Cancer.
BMC cancer, 8(1) 2008, 98.
(PMID 18405350)
|
|
| aCGH: 1
banding: 1 |
Schell AJ, Xu Y, Baetz T, Harrison K, Ropchan G, Lebrun D, and Feilotter H.
Primary cardiac lymphoma: molecular cytogenetic characterization of a rare entity.
Cardiovasc Pathol, 2008.
(PMID 18402841)
|
|
| aCGH: 24
|
Yi Y, Nowak NJ, Pacchia AL, and Morrison C.
Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
Genes Chromosomes Cancer, 47(8) 2008, 639-48.
(PMID 18398822)
|
|
| aCGH: 66
|
Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, et al.
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.
J Clin Invest, 118(5) 2008, 1739-49.
(PMID 18398503)
|
|
| aCGH: 11
|
Wiedemeyer R, Brennan C, Heffernan TP, Xiao Y, Mahoney J, Protopopov A, Zheng H, et al.
Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development.
Cancer Cell, 13(4) 2008, 355-64.
(PMID 18394558)
|
|
| aCGH: 57
|
Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, Reyal F, et al.
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Clin Cancer Res, 14(7) 2008, 1956-65.
(PMID 18381933)
|
|
| aCGH: 24
|
Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K, Hirohashi S, et al.
Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic . . .
Cancer Sci, 99(5) 2008, 986-94.
(PMID 18380791)
|
|
| CGH: 61
aCGH: 22
|
Hoischen A, Ehrler M, Fassunke J, Simon M, Baudis M, Landwehr C, Radlwimmer B, et al.
Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH.
Brain Pathol, 18(3) 2008, 326-37.
(PMID 18371186)
|
|
| aCGH: 87
|
Ferreira B, García J, Suela J, Mollejo M, Camacho F, Carro A, Montes S, Piris M, et al.
Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell . . .
Haematologica, 2008, .
(PMID 18367492)
|
|
| aCGH: 18
|
Jiang M, Li M, Fu X, Huang Y, Qian H, Sun R, Mao Y, Xie Y, and Li Y.
Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Prostate, 68(14) 2008, 1496-509.
(PMID 18366025)
|
|
| aCGH: 27
|
Aarhus M, Bruland O, Bredholt G, Lybaek H, Husebye ES, Krossnes BK, Vedeler C, et al.
Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas.
J Neurooncol, 88(3) 2008, 251-59.
(PMID 18365142)
|
|
| aCGH: 2
banding: 2 |
Ehemann V, Kern MA, Breinig M, Schnabel PA, Gunawan B, Schulten HJ, Schlaeger C, et al.
Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma.
Int J Cancer, 122(12) 2008, 2719-25.
(PMID 18360827)
|
|
| aCGH: 1
|
Nagashima T, Suzuki T, Kondo S, Kuroki Y, Takahashi K, Ide K, Yumoto N, Hasegawa A, et al.
Integrative genome-wide expression analysis bears evidence of estrogen receptor-independent transcription in heregulin-stimulated MCF-7 cells.
PLoS ONE, 3(3) 2008, e1803.
(PMID 18350142)
|
|
| aCGH: 10
|
Ruosaari ST, Nymark PE, Aavikko MM, Kettunen E, Knuutila S, Hollmen J, Norppa H, et al.
Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro.
Carcinogenesis, 29(5) 2008, 913-17.
(PMID 18339684)
|
|
| aCGH: 51
|
Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, Lohr S, Wu TD, Cavet G, Zhang Z, et al.
High-resolution genomic and expression analyses of copy number alterations in breast tumors.
Genes Chromosomes Cancer, 47(6) 2008, 530-42.
(PMID 18335499)
|
|
| aCGH: 17
|
Bernheim A, Toujani S, Saulnier P, Robert T, Casiraghi O, Validire P, Temam S, et al.
High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma.
Lab Invest, 88(5) 2008, 464-73.
(PMID 18332873)
|
|
| aCGH: 36
|
Kang JU, Koo SH, Kwon KC, Park JW, and Kim JM.
Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
Cancer Genet Cytogenet, 182(1) 2008, 1-11.
(PMID 18328944)
|
|
| aCGH: 54
|
Usvasalo A, Savola S, Raty R, Vettenranta K, Harila-Saari A, Koistinen P, et al.
CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study.
Leuk Res, 32(8) 2008, 1228-35.
(PMID 18328560)
|
|
| aCGH: 1
|
North JP, Kageshita T, Pinkel D, LeBoit PE, and Bastian BC.
Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.
J Invest Dermatol, 128(8) 2008, 2024-30.
(PMID 18323782)
|
|
| aCGH: 32
|
Gallegos Ruiz MI, Floor K, Roepman P, Rodriguez JA, Meijer GA, Mooi WJ, Jassem E, et al.
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.
PLoS ONE, 3(3) 2008, e0001722.
(PMID 18320023)
|
|
| aCGH: 29
|
Camps J, Grade M, Nguyen QT, Hormann P, Becker S, Hummon AB, Rodriguez V, et al.
Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome.
Cancer Res, 68(5) 2008, 1284-95.
(PMID 18316590)
|
|
| aCGH: 118
|
Han W, Jung E-M, Cho J, Lee JW, Hwang K-T, Yang S-J, Kang JJ, Bae J-Y, Jeon YK, et al.
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Genes, chromosomes cancer, 47(6) 2008, 490-99.
(PMID 18314908)
|
|
| aCGH: 50
|
Steinemann D, Cario G, Stanulla M, Karawajew L, Tauscher M, Weigmann A, Gohring G, et al.
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Genes Chromosomes Cancer, 47(6) 2008, 471-80.
(PMID 18311775)
|
|
| aCGH: 19
|
Tanaka S, Arii S, Yasen M, Mogushi K, Su NT, Zhao C, Imoto I, Eishi Y, Inazawa J, et al.
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy.
Br J Surg, 95(5) 2008, 611-19.
(PMID 18311747)
|
|
| aCGH: 21
|
Belaud-Rotureau MA, Marietta V, Vergier B, Mainhaguiet G, Turmo M, Idrissi Y, et al.
Inactivation of p16 (INK4a) /CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
Virchows Arch, 452(6) 2008, 607-20.
(PMID 18311490)
|
|
| aCGH: 1
banding: 1 |
Maire G, Brown CW, Bayani J, Pereira C, Gravel DH, Bell JC, Zielenska M, et al.
Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and . . .
Cancer Genet Cytogenet, 181(2) 2008, 81-92.
(PMID 18295659)
|
|
| aCGH: 2
|
Krona C, Caren H, Sjoberg RM, Sandstedt B, Laureys G, Kogner P, et al.
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
Int J Oncol, 32(3) 2008, 575-83.
(PMID 18292934)
|
|
| aCGH: 25
|
Stephan EA, Chung TH, Grant CS, Kim S, Von Hoff DD, Trent JM, et al.
Adrenocortical carcinoma survival rates correlated to genomic copy number variants.
Mol Cancer Ther, 7(2) 2008, 425-31.
(PMID 18281524)
|
|
| aCGH: 50
banding: 50 |
Rabin KR, Man TK, Yu A, Folsom MR, Zhao YJ, Rao PH, Plon SE, and Naeem RC.
Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer, 2008.
(PMID 18253961)
|
|
| aCGH: 20
|
Monzon FA, Hagenkord JM, Lyons-Weiler MA, Balani JP, Parwani AV, Sciulli CM, Li J, et al.
Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors.
Mod Pathol, 2008.
(PMID 18246049)
|
|
| aCGH: 12
|
Rund CR, Moser AJ, Lee KK, Zeh HJ, Teot LA, Dacic S, and Krasinskas AM.
Array comparative genomic hybridization analysis of solid pseudopapillary neoplasms of the pancreas.
Mod Pathol, 2008.
(PMID 18246043)
|
|
| aCGH: 38
|
Heidenblad M, Lindgren D, Jonson T, Liedberg F, Veerla S, Chebil G, Gudjonsson S, et al.
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced . . .
BMC medical genomics, 1 2008, 3.
(PMID 18237450)
|
|
| aCGH: 15
|
Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, Hsueh T, Chen Y, et al.
Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
PLoS Med, 5(1) 2008, e8.
(PMID 18215105)
|
|
| aCGH: 128
|
Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, Lee J, Choi YL, et al.
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.
Oncogene, 27(25) 2008, 3635-40.
(PMID 18212743)
|
|
| aCGH: 16
|
Sabatino M, Zhao Y, Voiculescu S, Monaco A, Robbins P, Karai L, Nickoloff BJ, Maio M, et al.
Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
Cancer Res, 68(1) 2008, 122-31.
(PMID 18172304)
|
|
| aCGH: 67
|
Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, Kleeff J, et al.
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
Hepatology, 47(2) 2008, 511-20.
(PMID 18161050)
|
|
| CGH: 10
aCGH: 26
|
Lindholm PM, Salmenkivi K, Vauhkonen H, Nicholson AG, Anttila S, Kinnula VL, et al.
Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH.
Cytogenet Genome Res, 119(1-2) 2007, 46-52.
(PMID 18160781)
|
|
| aCGH: 15
|
Vauhkonen H, Vauhkonen M, Sipponen P, and Knuutila S.
Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas.
Cytogenet Genome Res, 119(1-2) 2007, 39-45.
(PMID 18160780)
|
|
| aCGH: 37
|
Savola S, Nardi F, Scotlandi K, Picci P, and Knuutila S.
Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma.
Cytogenet Genome Res, 119(1-2) 2007, 21-26.
(PMID 18160777)
|
|
| aCGH: 44
|
Bollet MA, Servant N, Neuvial P, Decraene C, Lebigot I, Meyniel JP, De Rycke Y, et al.
High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
J Natl Cancer Inst, 100(1) 2008, 48-58.
(PMID 18159071)
|
|
| aCGH: 13
|
Kagawa N, Maruno M, Suzuki T, Hashiba T, Hashimoto N, Izumoto S, et al.
Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Brain Tumor Pathol, 23(1) 2006, 41-47.
(PMID 18095118)
|
|
| aCGH: 116
|
Jacinto FV, Ballestar E, Ropero S, and Esteller M.
Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells.
Cancer Res, 67(24) 2007, 11481-86.
(PMID 18089774)
|
|
| aCGH: 141
|
Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, et al.
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.
Proc. Natl. Acad. Sci. U.S.A, 104(50) 2007, 20007-12.
(PMID 18077431)
|
|
| aCGH: 40
|
Iwamoto K, Bundo M, Ueda J, Nakano Y, Ukai W, Hashimoto E, Saito T, et al.
Detection of chromosomal structural alterations in single cells by SNP arrays: a systematic survey of amplification bias and optimized workflow.
PLoS One, 2(12) 2007, e1306.
(PMID 18074030)
|
|
| aCGH: 30
|
Hallor KH, Staaf J, Jonsson G, Heidenblad M, Vult von Steyern F, Bauer HC, et al.
Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation.
Br J Cancer, 98(2) 2008, 434-42.
(PMID 18071362)
|
|
| aCGH: 1
banding: 2 |
Woo KS, Sung KS, Kim KU, Shaffer LG, and Han JY.
Characterization of complex chromosome aberrations in a recurrent meningioma combining standard cytogenetic and array comparative genomic hybridization techniques.
Cancer Genet Cytogenet, 180(1) 2008, 56-59.
(PMID 18068535)
|
|
| aCGH: 2
|
Hes O, Michal M, Sima R, Vanecek T, Brunelli M, Martignoni G, Kuroda N, et al.
Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features.
Virchows Arch, 2007.
(PMID 18066590)
|
|
| aCGH: 49
|
Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, and Cowell JK.
Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
Clin Cancer Res, 13(23) 2007, 7022-28.
(PMID 18056178)
|
|
| aCGH: 5
|
de Jong J, Stoop H, Gillis AJM, Hersmus R, van Gurp RJHLM, van de Geijn G-JM, Van Drunen E, Beverloo HB, Schneider DT, Sherlock JK, Baeten J, Kitazawa S, van Zoelen EJ, van Roozendaal K, Oosterhuis JW, and Looijenga LHJ.
Further characterization of the first seminoma cell line TCam-2.
Genes, chromosomes & cancer, 47(3) 2008, 185-96.
(PMID 18050305)
|
|
| aCGH: 87
|
Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T, Hosoda F, Imoto I, Inazawa J, et al.
Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
Gastroenterology, 133(5) 2007, 1475-86.
(PMID 17983802)
|
|
| CGH: 4
aCGH: 4
|
Selvarajah S, Yoshimoto M, Maire G, Paderova J, Bayani J, Squire JA, et al.
Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization.
Cancer Genet Cytogenet, 179(1) 2007, 52-61.
(PMID 17981215)
|
|
| aCGH: 1
banding: 1 |
Holland H, Koschny R, Krupp W, Meixensberger J, Bauer M, Schober R, Kirsten H, et al.
Cytogenetic and molecular biological characterization of an adult medulloblastoma.
Cancer Genet Cytogenet, 178(2) 2007, 104-13.
(PMID 17954265)
|
|
| aCGH: 27
|
Harada T, Chelala C, Bhakta V, Chaplin T, Caulee K, Baril P, Young BD, et al.
Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.
Oncogene, 27(13) 2008, 1951-60.
(PMID 17952125)
|
|
| aCGH: 26
|
Ferreira BI, Alonso J, Carrillo J, Acquadro F, Largo C, Suela J, Teixeira MR, et al.
Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewings sarcoma.
Oncogene, 27(14) 2008, 2084-90.
(PMID 17952124)
|
|
| aCGH: 74
|
Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, et al.
In vivo differentiation and genomic evolution in adult male germ cell tumors.
Genes Chromosomes Cancer, 47(1) 2008, 43-55.
(PMID 17943972)
|
|
| aCGH: 220
|
Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, et al.
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
Genome Biol, 8(10) 2007, R215.
(PMID 17925008)
|
|
| aCGH: 37
|
Johnson JE, Gettings EJ, Schwalm J, Pei J, Testa JR, Litwin S, von Mehren M, et al.
Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms.
Cancer Res, 67(19) 2007, 9221-28.
(PMID 17909028)
|
|
| aCGH: 30
|
Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, et al.
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
Clin Cancer Res, 13(19) 2007, 5745-55.
(PMID 17908964)
|
|
| aCGH: 3
banding: 3 |
Lundin C, Heidenblad M, Strombeck B, Borg A, Hovland R, Heim S, et al.
Tiling resolution array CGH of dic(7;9)(p11 approximately 13;p11 approximately 13) in B-cell precursor acute lymphoblastic leukemia reveals clustered breakpoints at 7p11.2 approximately 12.1 . . .
Cytogenet Genome Res, 118(1) 2007, 13-18.
(PMID 17901695)
|
|
| aCGH: 20
|
Tyybakinoja A, Vilpo J, and Knuutila S.
High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia.
Cytogenet Genome Res, 118(1) 2007, 8-12.
(PMID 17901694)
|
|
| CGH: 24
aCGH: 34
|
Jones A, Thirlwell C, Howarth K, Graham T, Chambers W, Segditsas S, Page K, et al.
Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas.
J Pathol, 2007.
(PMID 17893889)
|
|
| aCGH: 64
|
Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P, Ferrari M, et al.
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.
Cancer Res, 67(18) 2007, 8504-10.
(PMID 17875689)
|
|
| aCGH: 10
|
Vauhkonen H, Bohling T, Eissa S, Shoman S, and Knuutila S.
Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
Cancer Genet Cytogenet, 177(2) 2007, 153-57.
(PMID 17854674)
|
|
| aCGH: 71
|
Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, et al.
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Breast Cancer Res, 9(5) 2007, R59.
(PMID 17850661)
|
|
| aCGH: 1
|
Do JH, Kim IS, Park TK, and Choi DK.
Genome-wide Examination of Chromosomal Aberrations in Neuroblastoma SH-SY5Y Cells by Array-based Comparative Genomic Hybridization.
Mol Cells, 24(1) 2007, 105-12.
(PMID 17846504)
|
|
| aCGH: 13
banding: 13 |
Evers C, Beier M, Poelitz A, Hildebrandt B, Servan K, Drechsler M, Germing U, et al.
Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array . . .
Genes Chromosomes Cancer, 2007.
(PMID 17823930)
|
|
| aCGH: 107
|
Michels E, Vandesompele J, De Preter K, Hoebeeck J, Vermeulen J, Schramm A, et al.
ArrayCGH-based classification of neuroblastoma into genomic subgroups.
Genes Chromosomes Cancer, 2007.
(PMID 17823929)
|
|
| aCGH: 21
|
Kimm LR, Deleeuw RJ, Savage KJ, Rosenwald A, Campo E, Delabie J, Ott G, et al.
Frequent occurrence of deletions in primary mediastinal B-cell lymphoma.
Genes Chromosomes Cancer, 2007.
(PMID 17823928)
|
|
| aCGH: 62
|
Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, Kumar-Sinha C, Cao X, et al.
Integrative analysis of genomic aberrations associated with prostate cancer progression.
Cancer Res, 67(17) 2007, 8229-39.
(PMID 17804737)
|
|
| aCGH: 5
|
Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, et al.
Mistaken Identity of Widely Used Esophageal Adenocarcinoma Cell Line TE-7.
Cancer Res, 67(17) 2007, 7996-8001.
(PMID 17804709)
|
|
| aCGH: 39
|
Wessendorf S, Barth TF, Viardot A, Mueller A, Kestler HA, Kohlhammer H, Lichter P, et al.
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling . . .
Leukemia, 2007.
(PMID 17728785)
|
|
| aCGH: 11
|
Duerig J, Bug S, Klein-Hitpass L, Boes T, Joens T, Martin-Subero JI, Harder L, et al.
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the . . .
Leukemia, 2007, .
(PMID 17713554)
|
|
| CGH: 11
aCGH: 11
|
Kamradt J, Jung V, Wahrheit K, Tolosi L, Rahnenfuehrer J, Schilling M, Walker R, et al.
Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
PLoS ONE, 2(1) 2007, e769.
(PMID 17712417)
|
|
| aCGH: 31
|
Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, et al.
High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
Clin. Cancer Res, 13(16) 2007, 4731-39.
(PMID 17699850)
|
|
| aCGH: 66
|
Brazma D, Grace C, Howard J, Melo JV, Holyoke T, Apperley JF, et al.
Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression.
Genes Chromosomes Cancer, 46(11) 2007, 1039-50.
(PMID 17696194)
|
|
| aCGH: 17
|
Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R, Mazzocco K, et al.
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
Cancer Genet Cytogenet, 177(1) 2007, 20-29.
(PMID 17693187)
|
|
| aCGH: 17
banding: 17 |
Lilljebjorn H, Heidenblad M, Nilsson B, Lassen C, Horvat A, Heldrup J, Behrendtz M, et al.
Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq . . .
Leukemia, 2007.
(PMID 17690704)
|
|
| aCGH: 11
|
(PMID 17676035)
|
|
| aCGH: 28
|
Nowee M, Snijders A, Rockx D, de Wit R, Kosma V, Hamalainen K, Schouten J, et al.
DNA profiling of primary serous ovarian and Fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification.
J Pathol, 213(1) 2007, 46-55.
(PMID 17668415)
|
|
| aCGH: 236
|
Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, et al.
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
Oncogene, 27(4) 2008, 441-49.
(PMID 17637744)
|
|
| aCGH: 30
|
Lo KC, Rossi MR, LaDuca J, Hicks DG, Turpaz Y, Hawthorn L, and Cowell JK.
Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes.
Genes Chromosomes Cancer, 46(10) 2007, 875-94.
(PMID 17620294)
|
|
| aCGH: 2
|
Zanazzi C, Hersmus R, Veltman IM, Gillis AJM, Van Drunen E, Beverloo HB, et al.
Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.
Genes, chromosomes & cancer, 46(10) 2007, 895-908.
(PMID 17620293)
|
|
| aCGH: 10
banding: 10 |
Davidsson J, Andersson A, Paulsson K, Heidenblad M, Isaksson M, Borg A, Heldrup J, et al.
Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias . . .
Hum Mol Genet, 16(18) 2007, 2215-25.
(PMID 17613536)
|
|
| aCGH: 80
|
Tagawa H, Karube K, Guo Y, Takeshita M, Kikuchi M, Morishima Y, Nakamura S, et al.
Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma.
Leukemia, 21(12) 2007, 2549-51.
(PMID 17611568)
|
|
| CGH: 15
aCGH: 23
|
Ghazani AA, Arneson N, Warren K, Pintilie M, Bayani J, Squire JA, et al.
Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.
Neoplasia, 9(6) 2007, 511-20.
(PMID 17603634)
|
|
| aCGH: 10
|
Pfister S, Remke M, Toedt G, Werft W, Benner A, Mendrzyk F, Wittmann A, Devens F, et al.
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from . . .
Genes Chromosomes Cancer, 46(9) 2007, 839-51.
(PMID 17592618)
|
|
| aCGH: 30
|
Lastowska M, Viprey V, Santibanez-Koref M, Wappler I, Peters H, Cullinane C, et al.
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Oncogene, 26(53) 2007, 7432-44.
(PMID 17533364)
|
|
| CGH: 19
aCGH: 9
|
Adesina AM, Nguyen Y, Mehta V, Takei H, Stangeby P, Crabtree S, Chintagumpala M, et al.
FOXG1 dysregulation is a frequent event in medulloblastoma.
J Neurooncol, 85(2) 2007, 111-22.
(PMID 17522785)
|
|
| aCGH: 8
|
Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A, ONeil J, et al.
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.
Nature, 447(7147) 2007, 966-71.
(PMID 17515920)
|
|
| aCGH: 55
|
Fitzgibbon J, Iqbal S, Davies A, Oshea D, Carlotti E, Chaplin T, Matthews J, et al.
Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma.
Leukemia, 21(7) 2007, 1514-20.
(PMID 17495976)
|
|
| aCGH: 46
|
Kim WS, Honma K, Karnan S, Tagawa H, Kim YD, Oh YL, Seto M, and Ko YH.
Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma.
Genes Chromosomes Cancer, 2007.
(PMID 17492759)
|
|
| aCGH: 29
|
Fukuhara N, Nakamura T, Nakagawa M, Tagawa H, Takeuchi I, Yatabe Y, Morishima Y, et al.
Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomas.
Genes Chromosomes Cancer, 2007.
(PMID 17492756)
|
|
| aCGH: 30
|
Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, Chari R, Ge Y, et al.
Whole-Genome Analysis and HLA Genotyping of Enteropathy-Type T-Cell Lymphoma Reveals 2 Distinct Lymphoma Subtypes.
Gastroenterology, 132(5) 2007, 1902-11.
(PMID 17484883)
|
|
| aCGH: 14
|
Adduci KM, Annis CE, Devries S, Chew KL, Boutin J, Magrane G, Ljung BM, Waldman FM, et al.
Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
Cancer, 2007.
(PMID 17474121)
|
|
| aCGH: 23
|
Hirasaki S, Noguchi T, Mimori K, Onuki J, Morita K, Inoue H, Sugihara K, Mori M, et al.
BAC Clones Related to Prognosis in Patients with Esophageal Squamous Carcinoma: An Array Comparative Genomic Hybridization Study.
Oncologist, 12(4) 2007, 406-17.
(PMID 17470683)
|
|
| aCGH: 22
|
Lo KC, Rossi MR, Eberhart CG, and Cowell JK.
Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.
Brain Pathol, 17(3) 2007, 282-96.
(PMID 17465989)
|
|
| aCGH: 40
|
Kuiper RP, Schoenmakers EFPM, van Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, et al.
High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle . . .
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 21(6) 2007, 1258-66.
(PMID 17443227)
|
|
| aCGH: 557
|
Greshock J, Nathanson K, Martin AM, Zhang L, Coukos G, Weber BL, et al.
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.
Cancer Res, 67(8) 2007, 3594-600.
(PMID 17440070)
|
|
| aCGH: 27
|
Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, Lambert F, et al.
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia.
Nat Genet, 39(5) 2007, 593-95.
(PMID 17435759)
|
|
| aCGH: 23
|
Olejniczak ET, Van Sant C, Anderson MG, Wang G, Tahir SK, Sauter G, Lesniewski R, et al.
Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
Mol Cancer Res, 5(4) 2007, 331-39.
(PMID 17426248)
|
|
| aCGH: 59
|
Vincent-Salomon A, Gruel N, Lucchesi C, Macgrogan G, Dendale R, Sigal-Zafrani B, et al.
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
Breast Cancer Res, 9(2) 2007, R24.
(PMID 17417968)
|
|
| aCGH: 19
|
Fensterer H, Radlwimmer B, Strater J, Buchholz M, Aust DE, Julie C, Radvanyi F, et al.
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.
BMC Cancer, 7 2007, 58.
(PMID 17407575)
|
|
| aCGH: 19
|
Wicker N, Carles A, Mills IG, Wolf M, Veerakumarasivam A, Edgren H, Boileau F, et al.
A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH.
BMC genomics, 8 2007, 84.
(PMID 17394638)
|
|
| aCGH: 116
|
Price GR, Armes JE, Ramus SJ, Provenzano E, Kumar B, Cowie TF, Ciciulla J, et al.
Phenotype-directed analysis of genotype in early-onset, familial breast cancers.
Pathology, 38(6) 2006, 520-27.
(PMID 17393978)
|
|
| aCGH: 3
|
Korshunov A, Sycheva R, Golanov A, and Pronin I.
Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas.
Am J Clin Pathol, 127(4) 2007, 585-90.
(PMID 17369134)
|
|
| aCGH: 76
|
Stark M and Hayward N.
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Cancer Res, 67(6) 2007, 2632-42.
(PMID 17363583)
|
|
| aCGH: 3
|
Selvarajah S, Yoshimoto M, Prasad M, Shago M, Squire JA, Zielenska M, et al.
Characterization of trisomy 8 in pediatric undifferentiated sarcomas using advanced molecular cytogenetic techniques.
Cancer Genet Cytogenet, 174(1) 2007, 35-41.
(PMID 17350464)
|
|
| aCGH: 242
|
Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, et al.
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
Nature, 446(7137) 2007, 758-64.
(PMID 17344859)
|
|
| aCGH: 11
|
Jonsson G, Staaf J, Olsson E, Heidenblad M, Vallon-Christersson J, Osoegawa K, et al.
High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Genes Chromosomes Cancer, 46(6) 2007, 543-58.
(PMID 17334996)
|
|
| aCGH: 50
|
Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, et al.
Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.
Clin Cancer Res, 13(5) 2007, 1466-71.
(PMID 17332290)
|
|
| CGH: 21
aCGH: 35
|
Assaemaeki R, Sarlomo-Rikala M, Lopez-Guerrero JA, Lasota J, Andersson LC, et al.
Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors.
Genes Chromosomes Cancer, 46(6) 2007, 564-76.
(PMID 17330260)
|
|
| aCGH: 22
|
George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, et al.
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays.
PLoS ONE, 2 2007, e255.
(PMID 17327916)
|
|
| aCGH: 1
|
Nakaya K, Yamagata HD, Arita N, Nakashiro KI, Nose M, Miki T, et al.
Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array.
Oncogene, 2007.
(PMID 17325662)
|
|
| aCGH: 9
|
Kaur S, Larramendy ML, Vauhkonen H, Bohling T, and Knuutila S.
Loss of TP53 in sarcomas with 17p12 to approximately p11 gain. A fine-resolution oligonucleotide array comparative genomic hybridization study.
Cytogenet Genome Res, 116(3) 2007, 153-57.
(PMID 17317953)
|
|
| CGH: 9
aCGH: 9
banding: 9 |
Kuchinskaya E, Nordgren A, Heyman M, Schoumans J, Corcoran M, Staaf J, Borg A, et al.
Tiling-resolution array-CGH reveals the pattern of DNA copy number alterations in acute lymphoblastic leukemia with 21q amplification: the result of telomere dysfunction and . . .
Leukemia, 21(6) 2007, 1327-30.
(PMID 17315016)
|
|
| aCGH: 10
|
Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, et al.
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical . . .
BMC Genomics, 8 2007, 53.
(PMID 17311676)
|
|
| aCGH: 25
|
Tyybakinoja A, Elonen E, Piippo K, Porkka K, and Knuutila S.
Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia.
Leukemia, 21(3) 2007, 571-74.
(PMID 17268525)
|
|
| aCGH: 4
|
Oosting J, Lips EH, van Eijk R, Eilers PH, Szuhai K, Wijmenga C, Morreau H, et al.
High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArrays.
Genome Res, 17(3) 2007, 368-76.
(PMID 17267813)
|
|
| aCGH: 47
|
Jonsson G, Dahl C, Staaf J, Sandberg T, Bendahl PO, Ringner M, Guldberg P, et al.
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Oncogene, 26(32) 2007, 4738-48.
(PMID 17260012)
|
|
| aCGH: 29
|
Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, et al.
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes.
Genes Chromosomes Cancer, 46(4) 2007, 373-84.
(PMID 17243165)
|
|
| CGH: 3
aCGH: 3
banding: 3 |
Meyer S, Fergusson WD, Whetton AD, Moreira-Leite F, Pepper SD, Miller C, Saunders EK, et al.
Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
Genes Chromosomes Cancer, 46(4) 2007, 359-72.
(PMID 17243162)
|
|
| aCGH: 23
|
Harada T, Baril P, Gangeswaran R, Kelly G, Chelala C, Bhakta V, Caulee K, Mahon PC, et al.
Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation.
Br J Cancer, 96(2) 2007, 373-82.
(PMID 17242705)
|
|
| aCGH: 48
banding: 44 |
Strefford JC, Worley H, Barber K, Wright S, Stewart AR, Robinson HM, Bettney G, et al.
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization.
Oncogene, 2007.
(PMID 17237825)
|
|
| aCGH: 185
|
Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, Albertson D, Gray J, et al.
Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer.
Cancer research, 67(2) 2007, 818.
(PMID 17234794)
|
|
| aCGH: 44
|
Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, et al.
Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome.
Cancer Sci, 98(3) 2007, 392-400.
(PMID 17233815)
|
|
| aCGH: 30
|
Yang S, Jeung HC, Jeong HJ, Choi YH, Kim JE, Jung JJ, Rha SY, Yang WI, et al.
Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer.
Genomics, 2007.
(PMID 17229543)
|
|
| aCGH: 11
|
Finn S, Smyth P, ORegan E, Cahill S, Toner M, Timon C, Flavin R, OLeary J, et al.
Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors . . .
Arch Pathol Lab Med, 131(1) 2007, 65-73.
(PMID 17227125)
|
|
| aCGH: 16
|
Adesina AM, Nguyen Y, Guanaratne P, Pulliam J, Lopez-Terrada D, Margolin J, et al.
FOXG1 is overexpressed in hepatoblastoma.
Hum Pathol, 2007.
(PMID 17217994)
|
|
| aCGH: 10
|
Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, Hautmann RE, Fridyland J, Simko J, et al.
Genomic profiling of hormone-naive lymph node metastases in patients with prostate cancer.
Neoplasia, 8(12) 2006, 1083-89.
(PMID 17217626)
|
|
| CGH: 6
aCGH: 6
|
Carr J, Bown NP, Case MC, Hall AG, Lunec J, and Tweddle DA.
High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
Cancer Genet Cytogenet, 172(2) 2007, 127-38.
(PMID 17213021)
|
|
| CGH: 1
aCGH: 2
|
Rennstam K, Jonsson G, Tanner M, Bendahl PO, Staaf J, Kapanen AI, Karhu R, et al.
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
Cancer Genet Cytogenet, 172(2) 2007, 95-106.
(PMID 17213017)
|
|
| aCGH: 2
|
Gratias S, Rieder H, Ullmann R, Klein-Hitpass L, Schneider S, Boloni R, Kappler M, et al.
Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma.
Cancer Res, 67(1) 2007, 408-16.
(PMID 17210724)
|
|
| aCGH: 33
|
Bartos JD, Gaile DP, McQuaid DE, Conroy JM, Darbary H, Nowak NJ, Block A, Petrelli NJ, et al.
aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and . . .
Mutat Res, 615(1-2) 2007, 1-11.
(PMID 17196995)
|
|
| CGH: 1
aCGH: 1
banding: 1 |
Hallor KH, Heidenblad M, Brosjo O, Mandahl N, and Mertens F.
Tiling resolution array comparative genomic hybridization analysis of a fibrosarcoma of bone.
Cancer Genet Cytogenet, 172(1) 2007, 80-83.
(PMID 17175386)
|
|
| aCGH: 2
banding: 2 |
Schaub R, Burger A, Bausch D, Niggli FK, Schafer BW, and Betts DR.
Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
Cancer Genet Cytogenet, 172(1) 2007, 61-65.
(PMID 17175381)
|
|
| aCGH: 1
|
Szuhai K, IJszenga M, Tanke HJ, Taminiau AH, de Schepper A, van Duinen SG, et al.
Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma.
Cancer Genet Cytogenet, 172(1) 2007, 12-22.
(PMID 17175374)
|
|
| aCGH: 19
|
Clifford SC, Lusher ME, Lindsey JC, Langdon JA, Gilbertson RJ, Straughton D, et al.
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.
Cell Cycle, 5(22) 2006, 2666-70.
(PMID 17172831)
|
|
| aCGH: 66
banding: 46 |
Wozniak A, Sciot R, Guillou L, Pauwels P, Wasag B, Stul M, Vermeesch JR, et al.
Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational . . .
Genes Chromosomes Cancer, 46(3) 2007, 261-76.
(PMID 17171690)
|
|
| aCGH: 17
|
Lombardi L, Poretti G, Mattioli M, Fabris S, Agnelli L, Bicciato S, Kwee I, et al.
Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
Genes, chromosomes & cancer, 46(3) 2007, 226-38.
(PMID 17171682)
|
|
| aCGH: 37
|
Chen W, Salto-Tellez M, Palanisamy N, Ganesan K, Hou Q, Tan LK, Sii LH, Ito K, Tan B, et al.
Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Genes Chromosomes Cancer, 46(3) 2007, 288-301.
(PMID 17171680)
|
|
| aCGH: 22
|
Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, Monni O, Kallioniemi O, et al.
Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes.
Cell Oncol, 28(5-6) 2006, 315-26.
(PMID 17167184)
|
|
| aCGH: 24
|
Carvalho B, Buffart TE, Reis RM, Mons T, Moutinho C, Silva P, van Grieken NC, et al.
Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components.
Cell Oncol, 28(5-6) 2006, 283-94.
(PMID 17167181)
|
|
| aCGH: 35
|
Flordal Thelander E, Ichimura K, Collins VP, Walsh SH, Barbany G, Hagberg A, et al.
Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.
Leuk Res, 2006.
(PMID 17161458)
|
|
| aCGH: 145
|
Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, et al.
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Cancer Cell, 10(6) 2006, 529-41.
(PMID 17157792)
|
|
| aCGH: 53
|
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, et al.
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell, 10(6) 2006, 515-27.
(PMID 17157791)
|
|
| aCGH: 22
|
Lassmann S, Weis R, Makowiec F, Roth J, Danciu M, Hopt U, and Werner M.
Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
J Mol Med, 2006.
(PMID 17143621)
|
|
| aCGH: 61
|
Pierga JY, Reis-Filho JS, Cleator SJ, Dexter T, Mackay A, Simpson P, Fenwick K, et al.
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy.
Br J Cancer, 96(2) 2007, 341-51.
(PMID 17133270)
|
|
| aCGH: 30
|
Jonkers YM, Claessen SM, Veltman JA, Geurts van Kessel A, Dinjens WN, Skogseid B, et al.
Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.
Cytogenet Genome Res, 115(3-4) 2006, 289-97.
(PMID 17124412)
|
|
| aCGH: 20
|
Korshunov A, Sycheva R, and Golanov A.
Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance.
Acta Neuropathol (Berl), 113(3) 2007, 303-12.
(PMID 17123091)
|
|
| aCGH: 13
|
van Dieren JM, Wink JC, Vissers KJ, van Marion R, Hoogmans MM, Dinjens WN, et al.
Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis.
Diagn Mol Pathol, 15(4) 2006, 216-22.
(PMID 17122649)
|
|
| aCGH: 47
|
Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP, Dawson AE, Budd GT, et al.
Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients.
Clin Cancer Res, 12(22) 2006, 6702-08.
(PMID 17121889)
|
|
| CGH: 13
aCGH: 13
|
Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, Grigoriadis A, et al.
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
Clin Cancer Res, 12(22) 2006, 6652-62.
(PMID 17121884)
|
|
| aCGH: 46
|
Buffart TE, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Schaaij-Visser TB, Eijk PP, et al.
Gastric cancers in young and elderly patients show different genomic profiles.
J Pathol, 211(1) 2007, 45-51.
(PMID 17117405)
|
|
| CGH: 2
aCGH: 22
|
Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, et al.
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
J Clin Oncol, 24(33) 2006, 5223-33.
(PMID 17114655)
|
|
| aCGH: 37
|
Maher EA, Brennan C, Wen PY, Durso L, Ligon KL, Richardson A, Khatry D, Feng B, et al.
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.
Cancer Res, 66(23) 2006, 11502-13.
(PMID 17114236)
|
|
| aCGH: 14
|
Choi YW, Choi JS, Zheng LT, Lim YJ, Yoon HK, Kim YH, Wang YP, et al.
Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung.
Lung Cancer, 55(1) 2007, 43-51.
(PMID 17109992)
|
|
| aCGH: 57
|
Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, de Medina SG, Segraves R, et al.
Regional copy number-independent deregulation of transcription in cancer.
Nat Genet, 38(12) 2006, 1386-96.
(PMID 17099711)
|
|
| aCGH: 59
|
Kim MY, Yim SH, Kwon MS, Kim TM, Shin SH, Kang HM, Lee C, and Chung YJ.
Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
Gastroenterology, 131(6) 2006, 1913-24.
(PMID 17087931)
|
|
| aCGH: 44
|
Jones DT, Ichimura K, Liu L, Pearson DM, Plant K, and Collins VP.
Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.
J Neuropathol Exp Neurol, 65(11) 2006, 1049-58.
(PMID 17086101)
|
|
| aCGH: 46
|
Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, Kakar S, Fridlyand J, et al.
Chromosomal instability in microsatellite-unstable and stable colon cancer.
Clin Cancer Res, 12(21) 2006, 6379-85.
(PMID 17085649)
|
|
| aCGH: 27
|
Jonkers YM, Claessen SM, Feuth T, van Kessel AG, Ramaekers FC, Veltman JA, et al.
Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
J Pathol, 210(4) 2006, 450-58.
(PMID 17068744)
|
|
| aCGH: 70
|
Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, Fisch P, Timmer J, et al.
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
Blood, 109(3) 2007, 1202-10.
(PMID 17053054)
|
|
| aCGH: 17
|
Kim SW, Kim JW, Kim YT, Kim JH, Kim S, Yoon BS, Nam EJ, and Kim HY.
Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant . . .
Genes Chromosomes Cancer, 46(1) 2007, 1-9.
(PMID 17044060)
|
|
| aCGH: 61
|
Thorns C, Bastian B, Pinkel D, Roydasgupta R, Fridlyand J, Merz H, Krokowski M, et al.
Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach.
Genes Chromosomes Cancer, 46(1) 2007, 37-44.
(PMID 17044049)
|
|
| aCGH: 26
|
Lo KC, Rossi MR, Burkhardt T, Pomeroy SL, and Cowell JK.
Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in . . .
Genes Chromosomes Cancer, 46(1) 2007, 53-66.
(PMID 17044047)
|
|
| aCGH: 178
|
Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A, Heiss J, et al.
High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.
Cancer Res, 66(19) 2006, 9428-36.
(PMID 17018597)
|
|
| aCGH: 12
|
Saito S, Ghosh M, Morita K, Hirano T, Miwa M, and Todoroki T.
The genetic differences between gallbladder and bile duct cancer cell lines.
Oncol Rep, 16(5) 2006, 949-56.
(PMID 17016576)
|
|
| aCGH: 15
|
Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, and Knuutila S.
Characterizing genetically stable and unstable gastric cancers by microsatellites and array comparative genomic hybridization.
Cancer Genet Cytogenet, 170(2) 2006, 133-39.
(PMID 17011984)
|
|
| aCGH: 19
|
Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namlos HM, et al.
Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas.
Cancer Res, 66(18) 2006, 8984-93.
(PMID 16982739)
|
|
| aCGH: 34
|
Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, et al.
Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
Clin Gastroenterol Hepatol, 4(10) 2006, 1283-91.
(PMID 16979954)
|
|
| aCGH: 4
|
Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, et al.
Primary glioblastomas express mesenchymal stem-like properties.
Mol Cancer Res, 4(9) 2006, 607-19.
(PMID 16966431)
|
|
| CGH: 8
aCGH: 1
|
Yoshimoto M, Bayani J, Nuin PA, Silva NS, Cavalheiro S, Stavale JN, Andrade JA, et al.
Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America.
Cancer Genet Cytogenet, 170(1) 2006, 40-47.
(PMID 16965953)
|
|
| aCGH: 48
banding: 25 |
Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V, et al.
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
Blood, 109(1) 2007, 271-80.
(PMID 16960149)
|
|
| aCGH: 90
|
Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, et al.
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and . . .
Genes Chromosomes Cancer, 45(12) 2006, 1130-42.
(PMID 16958102)
|
|
| aCGH: 43
|
Kimmel RR, Zhao LP, Nguyen D, Lee S, Aronszajn M, Cheng C, Troshin VP, Abrosimov A, et al.
Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer.
Radiat Res, 166(3) 2006, 519-31.
(PMID 16953671)
|
|
| CGH: 59
aCGH: 10
|
Weber RG, Hoischen A, Ehrler M, Zipper P, Kaulich K, Blaschke B, Becker AJ, et al.
Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Oncogene, 26(7) 2007, 1088-97.
(PMID 16909113)
|
